Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023183	fp-nh4-ion	umol/l (umol/l)	8225	22308	0.14%
3023183	fp-nh4-ion	— (—)	1696	2415	100.00%	Distribution not available
3023183	p-nh4-ion	umol/l (umol/l)	450	1298	0.62%
3023183	fb-nh4-ion	umol/l (umol/l)	152	298	0.00%
3023183	fp-nh4-ion	umol/l____ (umol/l)	129	365	0.00%
3023183	fp-nh4-ion	µmol/L (umol/l)	66	181	0.00%
3023183	fp-nh4-ion	UMOL/L (umol/l)	29	61	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other antidepressants

2391

4876

2.56

321.10

2.7

32.82

34.03

umol/l

1.16

2161

4392

Depression medications

522

252

10.66

316.86

3.0

2.7

35.05

34.39

umol/l

0.10

487

229

Diseases of arteries, arterioles and capillaries (FINNGEN)

684

840

5.87

316.19

2.6

2.1

32.00

35.75

umol/l

1.60

622

746

Chronic pancreatitis

602

1112

5.95

314.98

3.3

2.7

37.68

34.80

umol/l

1.19

550

1001

Atrial fibrillation and flutter

806

1060

5.09

314.61

3.0

2.1

32.16

35.13

umol/l

1.54

734

951

Oedema, not elsewhere classified

899

2219

4.11

312.93

3.5

2.2

34.58

33.75

umol/l

0.40

815

1968

Anaemias

929

301

21.11

307.65

4.7

2.7

38.48

34.88

umol/l

1.30

870

275

Other medical care

1715

3640

4.15

307.65

2.7

2.5

35.73

33.49

umol/l

2.49

1553

3242

Non-invasive ventilation

765

742

9.34

307.65

3.0

2.4

30.41

36.36

umol/l

5.38

698

668

Explicit Sepsis

2179

2914

7.36

307.65

3.7

2.0

34.97

32.45

umol/l

3.37

1999

2595

Heart failure, strict

1926

4169

3.35

307.65

2.7

2.6

32.69

33.33

umol/l

0.45

1740

3719

Renal failure

2373

3946

5.54

307.65

3.5

2.3

34.16

32.88

umol/l

1.26

2154

3493

Any mental disorder

2868

4236

3.49

307.65

2.9

2.5

33.46

34.19

umol/l

0.57

2598

3825

Mood [affective] disorders

2558

6497

2.58

307.65

2.9

2.7

33.55

33.89

umol/l

0.22

2336

5865

Acute renal failure

1564

1919

9.34

307.65

3.8

2.2

35.12

33.06

umol/l

1.58

1434

1687

Certain infectious and parasitic diseases

2121

3586

3.03

307.65

3.1

2.3

34.31

33.00

umol/l

1.04

1924

3240

Malaise and fatigue

2203

2978

6.17

307.65

3.1

2.3

32.60

34.03

umol/l

1.39

1977

2671

Erysipelas

1591

4044

3.51

307.65

3.0

2.4

34.26

33.45

umol/l

0.43

1442

3611

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

584

549

13.10

307.65

4.6

2.5

42.14

35.45

umol/l

2.58

548

488

726

883

9.89

307.65

5.6

2.5

49.28

33.38

umol/l

17.01

684

796

All kidney diseases

3099

5786

3.72

307.65

3.3

2.5

33.52

33.99

umol/l

0.41

2824

5233

Metabolic disorders

2486

5262

2.91

307.65

3.2

2.7

34.11

34.14

umol/l

0.02

2252

4760

Septicaemia

2131

3207

6.55

307.65

3.7

2.3

35.06

33.08

umol/l

2.48

1954

2851

Erysipelas, including avohilmo

1928

4444

3.31

307.65

3.1

2.4

34.26

33.37

umol/l

0.57

1755

3967

Other disorders of fluid, electrolyte and acid-base balance

1725

2588

6.88

307.65

3.3

2.4

33.99

34.23

umol/l

0.10

1574

2303

Substance use, excluding alcohol

761

1299

6.25

307.65

2.5

2.9

33.72

34.02

umol/l

0.07

687

1205

Hepatocellular carcinoma, including Hilmo

380

253

21.56

307.65

5.5

2.7

43.60

39.43

umol/l

0.52

360

233

Suicide or other Intentional self-harm

930

1981

4.99

307.65

2.6

3.1

33.10

34.90

umol/l

0.79

836

1830

All pneumoniae

3056

6045

3.39

307.65

2.9

2.8

32.31

34.61

umol/l

4.36

2784

5470

Bacterial infection, other or unspecified, including avohilmo

2383

3970

5.21

307.65

3.0

2.4

32.07

33.14

umol/l

1.12

2141

3546

Explicit Sepsis, including avohilmo

2202

2970

7.25

307.65

3.7

2.0

34.95

32.50

umol/l

3.28

2018

2645

Viral Sepsis

944

1361

7.50

307.65

4.0

2.0

31.96

32.45

umol/l

0.18

861

1203

Iron deficiency anaemia

1454

4010

3.72

307.65

3.5

2.3

35.54

32.53

umol/l

3.53

1340

3550

Implicit viral Sepsis, including avohilmo

1245

2054

6.46

307.65

3.8

1.9

32.88

32.66

umol/l

0.09

1131

1828

Malignant neoplasm of liver and intrahepatic bile ducts

344

260

17.61

307.65

5.4

2.7

44.18

38.85

umol/l

0.74

327

237

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3583

4185

6.09

307.65

3.7

2.1

34.79

32.74

umol/l

3.34

3277

3775

Transplanted organ and tissue status

616

829

8.51

307.65

8.1

2.6

34.85

35.02

umol/l

0.05

595

751

Other and unspecified anaemias

1566

4060

3.81

307.65

3.9

2.2

36.62

32.24

umol/l

5.72

1417

3588

Substance abuse

2865

4788

5.98

307.65

3.2

2.6

35.30

33.19

umol/l

2.92

2591

4344

Mental and behavioural disorders due to psychoactive substance use

2906

4832

5.91

307.65

3.2

2.6

35.26

33.20

umol/l

2.88

2628

4385

Nutritional anaemias

1619

4597

3.50

307.65

3.4

2.3

35.31

32.57

umol/l

3.32

1481

4070

Bleeding

2682

5765

3.39

307.65

3.6

2.3

35.30

33.02

umol/l

3.85

2462

5144

Alcohol withdrawal state with delirium

615

679

11.31

307.65

3.5

3.1

34.63

34.24

umol/l

0.08

564

615

Pneumonias (Asthma/COPD co-morbidities)

3035

6033

3.40

307.65

2.8

32.27

34.60

umol/l

4.45

2767

5457

Alcohol abuse, main dg

807

1459

6.08

307.65

3.1

32.80

35.29

umol/l

1.49

738

1341

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2477

4027

6.67

307.65

3.3

2.6

35.77

33.49

umol/l

2.83

2244

3658

Poisoning by medicine

959

1645

6.29

307.65

2.5

3.0

32.54

34.73

umol/l

1.31

867

1516

Hepatocellular carcinoma

294

189

22.42

307.65

5.5

2.2

43.96

35.76

umol/l

2.40

281

170

Mood disorders, excluding more controls

2396

4085

3.55

307.65

2.9

2.5

33.47

34.24

umol/l

0.55

2183

3695

Heart failure,strict

1835

3079

4.38

307.65

2.8

2.1

32.78

32.63

umol/l

0.08

1674

2749

Other symptoms and signs involving cognitive functions and awareness

1677

4096

3.81

307.65

2.8

2.5

30.77

34.38

umol/l

6.46

1457

3701

Implicit viral Sepsis

944

1360

7.51

307.65

4.0

2.0

31.96

32.45

umol/l

0.18

861

1203

Status epilepticus

319

269

14.66

307.65

3.7

2.9

32.29

37.37

umol/l

0.77

298

240

Other bacterial diseases, including avohilmo

3457

5171

4.35

307.65

3.3

2.5

34.71

33.29

umol/l

1.87

3178

4645

Renal tubulo-interstitial diseases

3162

5593

4.34

307.65

3.3

2.5

33.41

33.83

umol/l

0.35

2869

5039

Other heart diseases

1227

1750

4.71

307.65

3.2

2.3

33.81

34.24

umol/l

0.18

1134

1594

Acute alcohol intoxication, ICD10

997

1776

6.12

307.65

3.1

2.8

33.33

33.25

umol/l

0.03

909

1633

Schizophrenia or delusion, excluding more controls

876

1664

5.43

307.65

2.0

2.8

30.91

34.19

umol/l

3.57

782

1519

Intracranial trauma

1583

2792

3.95

307.65

3.1

2.7

33.33

36.00

umol/l

3.03

1435

2558

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

467

425

13.63

307.65

4.7

2.2

43.11

35.69

umol/l

2.15

442

376

Cirrhosis of liver, NAS

1015

409

45.30

307.65

5.8

1.8

45.44

33.58

umol/l

4.98

979

354

Nephropathy related operations

806

1185

7.86

307.65

5.3

2.6

33.59

34.91

umol/l

0.49

750

1074

Alcoholic liver disease

1514

768

29.66

307.65

5.9

1.6

45.82

29.70

umol/l

45.45

1445

686

Other bacterial diseases

3581

5223

4.77

307.65

3.3

2.4

34.65

33.32

umol/l

1.73

3272

4688

Influenza and pneumonia

3073

5870

3.33

307.65

2.9

2.8

32.31

34.62

umol/l

4.45

2808

5311

Mood disorders

2560

6502

2.58

307.65

2.9

2.7

33.53

33.89

umol/l

0.24

2338

5870

Oesophageal varices

759

341

40.45

307.65

7.7

2.2

47.40

35.72

umol/l

3.88

741

293

STROKE

1430

2966

3.35

307.65

2.5

2.7

31.67

35.42

umol/l

5.43

1290

2685

Implicit bacterial Sepsis, including avohilmo

2549

2829

8.20

307.65

3.7

2.0

34.34

32.65

umol/l

1.69

2298

2519

Bacterial infection, other or unspecified

2270

3743

5.44

307.65

3.0

2.3

32.05

32.96

umol/l

0.85

2037

3337

Diseases of oesophagus, stomach and duodenum

2660

6241

2.58

307.65

3.6

2.4

35.58

32.77

umol/l

5.58

2447

5614

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3136

6190

3.54

307.65

3.6

2.3

35.87

32.49

umol/l

7.47

2877

5557

Injuries to the head

2799

6780

2.50

307.65

2.8

2.7

33.28

33.77

umol/l

0.43

2520

6139

Implicit Sepsis, including avohilmo

3622

4259

6.46

307.65

3.6

2.1

34.57

32.85

umol/l

2.42

3305

3819

Chronic kidney disease

1218

2785

4.46

307.65

3.2

2.2

31.02

32.59

umol/l

1.12

1097

2444

Alcohol abuse, main dg, excluding more controls

807

865

10.34

307.65

3.1

32.80

35.01

umol/l

1.24

738

807

Anxiety disorders, excluding more controls

1861

3700

3.29

307.65

2.8

2.6

33.34

34.50

umol/l

1.09

1685

3357

Caries of dentine

949

2089

4.66

307.65

4.7

2.6

35.49

34.00

umol/l

1.00

879

1907

Other diseases of the digestive system

1347

3179

4.52

307.65

4.7

2.2

39.57

31.88

umol/l

15.78

1248

2805

Diseases of the digestive system

1637

4638

3.67

307.65

4.5

2.2

38.05

32.16

umol/l

12.97

1515

4109

General symptoms and signs

2788

3852

3.73

307.65

3.2

2.4

34.16

34.20

umol/l

0.02

2544

3468

Insulin medication

1833

4995

3.15

307.65

3.5

2.4

35.49

32.90

umol/l

3.74

1675

4481

Implicit Sepsis

3506

4136

6.67

307.65

3.6

2.1

34.46

32.79

umol/l

2.26

3189

3707

Poisoning by drugs, medicaments and biological substances

1023

1802

6.10

307.65

2.5

3.1

32.33

34.66

umol/l

1.60

926

1657

Dental caries

1058

2365

4.48

307.65

5.0

2.6

35.79

34.00

umol/l

1.42

981

2161

GI-bleeding

1346

3185

4.50

307.65

4.7

2.2

39.56

31.88

umol/l

15.65

1246

2804

Pneumonia, organism unspecified

2803

5696

3.49

307.65

2.8

32.26

34.77

umol/l

4.66

2545

5149

Acute tubulo-interstitial nephritis

1611

4486

3.12

307.65

2.8

2.4

30.94

33.39

umol/l

3.74

1433

4009

All chronic kidney diseases

1887

3918

4.02

307.65

3.2

2.4

32.53

33.55

umol/l

0.82

1701

3503

Heart failure and antihypertensive medication

1023

939

7.59

307.65

3.4

2.2

33.64

34.07

umol/l

0.12

943

845

Other septicaemia, including avohilmo

1983

2981

6.77

307.65

3.7

2.3

35.14

32.70

umol/l

3.38

1819

2651

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2991

6119

3.36

307.65

2.8

32.34

34.60

umol/l

4.21

2724

5539

Fever of other and unknown origin

1744

3467

4.53

307.65

3.4

2.4

33.98

34.09

umol/l

0.05

1605

3117

2589

4403

3.55

307.65

2.8

2.6

32.13

34.27

umol/l

3.17

2374

3972

Insulin, combination of fast acting with intermediate-acting or long-acting

1833

5968

2.88

307.65

3.5

2.5

35.49

33.06

umol/l

3.50

1675

5330

Any death

3024

3504

6.55

307.65

3.3

2.4

39.83

29.47

umol/l

51.22

2765

3138

3325

4261

7.62

307.65

3.7

2.2

37.74

31.37

umol/l

22.97

3042

3829

Unspecified jaundice

381

338

13.41

307.65

4.4

2.0

41.38

32.45

umol/l

4.67

352

303

All-cause Heart Failure

1869

4099

3.31

307.65

2.7

2.6

32.66

33.36

umol/l

0.50

1688

3656

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

969

2232

4.56

307.65

2.6

3.1

32.86

34.70

umol/l

0.87

873

2064

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

969

1285

7.87

307.65

2.6

3.0

32.86

34.51

umol/l

0.68

873

1188

Infections, IBD-co-morbidities

564

499

8.40

307.65

3.7

2.6

32.96

39.28

umol/l

3.20

519

463

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2261

1242

27.22

307.65

5.6

1.8

44.43

30.09

umol/l

35.63

2159

1105

Cerebrovascular diseases (FINNGEN)

992

1119

6.52

307.65

2.6

2.2

31.62

34.93

umol/l

2.07

906

1006

Symptoms and signs involving cognition, perception, emotional state and behaviour

2605

6409

2.79

307.65

2.8

2.7

31.96

34.47

umol/l

4.88

2325

5843

Diseases of liver

3062

2670

13.63

307.65

4.9

1.6

42.42

29.12

umol/l

76.23

2906

2359

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

511

415

15.91

307.65

5.0

2.5

43.28

35.73

umol/l

2.19

480

365

Substance abuse, excluding more controls

2865

3426

7.54

307.65

3.2

2.6

35.30

34.43

umol/l

0.66

2591

3106

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2589

4403

3.55

307.65

2.8

2.6

32.13

34.27

umol/l

3.17

2374

3972

Viral hepatitis, IBD co-morbidity

325

208

17.56

307.65

3.3

2.8

37.38

38.94

umol/l

0.31

303

199

Hepatic failure, not elsewhere classified

614

243

42.05

307.65

8.3

1.8

48.21

29.98

umol/l

16.48

593

210

Ascites

909

528

23.29

307.65

6.5

2.2

42.55

32.51

umol/l

11.23

865

473

Other septicaemia

1963

2924

6.88

307.65

3.7

2.3

35.18

32.67

umol/l

3.49

1803

2595

Hernia of abdominal wall, postoperative

535

751

7.41

307.65

4.7

1.6

37.36

30.15

umol/l

6.65

499

657

Fibrosis and cirrhosis of liver

1142

531

32.54

307.65

5.7

1.6

44.13

30.54

umol/l

20.32

1099

462

Dialysis, with operation codes

863

1059

9.46

307.65

5.2

2.5

34.23

34.49

umol/l

0.07

803

948

Aplastic and other anaemias

1688

4317

3.76

307.65

3.8

2.2

36.29

32.22

umol/l

5.52

1523

3825

Nausea and vomiting

896

1966

4.66

307.65

3.8

2.0

33.55

31.69

umol/l

0.82

808

1748

Alcohol use disorder, Swedish definition

3253

4125

7.88

307.65

3.7

2.2

37.92

31.32

umol/l

23.70

2976

3716

Personality disorders, excluding more controls

704

1210

6.05

307.65

2.4

3.1

34.01

35.11

umol/l

0.32

638

1118

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

736

1212

6.58

307.65

2.6

3.2

32.72

34.94

umol/l

1.11

658

1130

Alcohol use disorder, ICD-based

2273

3853

6.45

307.65

3.4

2.7

35.91

33.55

umol/l

2.77

2060

3507

Disorders of gallbladder, biliary tract and pancreas

2544

6258

2.59

307.65

3.3

2.5

34.94

33.10

umol/l

2.87

2350

5598

Other diseases of liver

886

1232

7.89

307.65

5.6

1.7

41.82

29.39

umol/l

17.21

847

1104

Other anaemias

1577

4087

3.80

307.65

3.9

2.2

36.64

32.26

umol/l

5.75

1424

3612

L04AD Calcineurin inhibitors

596

1024

6.52

307.65

7.6

2.8

34.68

35.36

umol/l

0.20

575

948

Oxycodone

1393

3023

4.13

307.65

2.8

2.3

35.31

32.83

umol/l

1.90

1249

2695

Concussion

1236

2773

3.55

307.65

3.0

2.7

32.55

36.02

umol/l

4.45

1113

2544

Epilepsy

1189

2910

4.30

307.65

2.9

2.8

32.41

34.51

umol/l

2.02

1076

2617

Anxiety (asthma-related co-morbidities)

1352

2987

3.53

307.65

2.6

2.8

33.12

33.76

umol/l

0.41

1223

2732

Insulin, intermediate and long-acting

1680

5657

2.97

307.65

3.4

2.5

35.64

32.98

umol/l

3.82

1530

5062

Other and unspecified iron deficiency

1099

3095

3.71

307.65

3.3

2.3

35.81

32.59

umol/l

2.84

1010

2733

Hypokalaemia

600

876

7.52

307.65

3.4

2.5

35.66

34.07

umol/l

0.41

554

794

Any gastric operation

1774

1780

5.13

307.65

3.2

1.6

35.61

30.30

umol/l

7.94

1640

1541

Implicit bacterial Sepsis

2427

2647

8.66

307.65

3.7

2.0

34.33

32.56

umol/l

1.72

2186

2354

Mental and behavioural disorders due to alcohol

2632

4325

6.27

307.65

3.3

2.6

35.49

33.25

umol/l

2.98

2385

3925

Heart failure, not strict

2972

4159

5.09

307.65

3.8

2.2

35.56

33.09

umol/l

3.80

2728

3735

Type 2 diabetes, wide definition

2020

4593

2.85

307.65

3.3

2.4

35.46

32.83

umol/l

3.76

1837

4107

Persons encountering health services for specific procedures and health care

3078

5650

3.31

307.65

2.9

2.7

33.80

33.82

umol/l

0.01

2819

5093

Depression

2353

6225

2.59

307.65

3.0

2.7

33.64

34.01

umol/l

0.23

2145

5635

Benzodiazepine use

2623

6881

2.64

307.65

2.8

2.7

33.40

33.69

umol/l

0.20

2376

6199

GASTRO-related operations

1774

1780

5.13

307.65

3.2

1.6

35.61

30.30

umol/l

7.94

1640

1541

Hypo-osmolality and hyponatraemia

921

1359

7.40

307.65

3.3

2.4

33.33

33.97

umol/l

0.30

840

1200

Convulsions, not elsewhere classified

1213

1460

8.92

307.65

3.0

2.4

33.77

33.66

umol/l

0.04

1116

1325

Tramadol

2113

4014

3.26

307.65

3.6

2.5

35.48

33.03

umol/l

2.88

1953

3617

Alcohol dependence

1466

2229

7.25

307.65

3.4

2.7

36.42

33.45

umol/l

2.51

1344

2044

Acute alcohol intoxication

1118

2098

5.72

307.65

3.0

2.7

33.98

33.52

umol/l

0.17

1020

1914

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1097

1448

4.93

307.65

5.3

2.3

39.37

34.64

umol/l

4.52

1042

1314

Delirium, not induced by alcohol and other psychoactive substances

833

1054

9.01

307.65

2.4

28.53

35.17

umol/l

6.14

721

938

Psychiatric diseases

2336

3695

3.25

307.65

2.9

2.6

33.64

34.65

umol/l

0.75

2107

3360

3369

4323

7.38

307.65

3.7

2.2

37.66

31.37

umol/l

22.83

3081

3884

Condition for Implicit Sepsis (Organ dysfunction codes)

3670

4169

6.47

307.65

3.6

2.1

34.73

32.73

umol/l

3.15

3348

3748

Bacterial Sepsis

2604

2920

8.05

307.65

3.6

2.0

34.28

32.67

umol/l

1.62

2348

2600

Gastroduodenal ulcer

909

2363

4.04

306.52

3.9

2.0

37.53

32.27

umol/l

5.44

821

2077

Fall on same level

2643

6117

2.35

301.96

3.1

2.7

33.64

34.05

umol/l

0.32

2386

5575

Malignant neoplasm of digestive organs, including Hilmo

1365

3280

3.19

298.29

3.1

2.7

37.59

33.01

umol/l

6.73

1252

2938

Cardiovascular diseases (excluding rheumatic etc)

1261

2110

3.49

297.89

3.6

2.4

34.88

33.72

umol/l

0.73

1181

1924

Organic, including symptomatic, mental disorders

1539

3769

2.98

297.73

2.3

2.4

28.55

33.91

umol/l

14.62

1326

3366

Acute pancreatitis

741

1704

4.63

297.09

3.5

2.6

36.56

33.76

umol/l

1.71

684

1529

Volume depletion

466

711

7.17

295.28

2.9

2.5

34.29

34.12

umol/l

0.03

421

632

Hypertensive diseases (excluding secondary)

1073

1649

3.88

293.98

3.8

2.3

35.01

34.54

umol/l

0.18

993

1499

Symptoms and signs involving the digestive system and abdomen

2254

4576

2.52

292.42

3.4

2.2

35.24

32.47

umol/l

4.04

2055

4072

Other inflammatory liver diseases

348

393

9.98

286.82

4.2

1.8

36.44

29.92

umol/l

4.33

328

348

Care involving use of rehabilitation procedures

1538

5131

2.76

279.82

2.7

30.98

33.78

umol/l

4.70

1425

4614

Intracranial injury

1548

5452

2.72

274.21

2.9

2.7

32.93

33.58

umol/l

0.46

1396

4911

Use of hypnotics and sedatives

2487

6368

2.28

270.31

2.9

2.7

33.91

33.74

umol/l

0.10

2261

5759

Other heart diseases, wide

2018

5022

2.48

269.00

3.1

2.9

33.55

34.79

umol/l

1.19

1843

4578

Cholangitis (primary sclerosing, PSC)

359

458

8.87

268.67

5.5

2.7

35.20

36.01

umol/l

0.13

332

415

Syncope and collapse

1082

2778

3.34

268.67

2.6

2.3

31.14

33.90

umol/l

3.25

962

2478

Cerebrovascular diseases

1927

5492

2.50

268.44

2.3

2.8

30.32

34.74

umol/l

12.40

1722

4935

Problems related to lifestyle

464

778

6.45

267.41

3.0

2.8

35.84

34.59

umol/l

0.24

433

708

Care involving dialysis

411

615

7.46

266.61

3.4

2.9

29.15

35.59

umol/l

2.85

378

556

Complications of surgical and medical care, not elsewhere classified

2343

6991

2.28

266.34

3.0

2.6

32.93

33.82

umol/l

0.88

2105

6303

Depression or dysthymia

1412

2585

3.05

266.32

3.2

2.5

34.08

34.71

umol/l

0.27

1275

2355

Other diseases of biliary tract

428

672

7.03

264.54

5.0

2.4

38.49

34.79

umol/l

1.10

396

594

Focal epilepsy

764

1962

4.12

263.95

2.8

31.49

34.29

umol/l

2.24

692

1775

Continuous positive airway pressure

485

665

6.33

262.26

2.6

34.41

36.56

umol/l

0.96

430

591

Insulin, fast-acting

1092

3542

3.21

261.74

3.7

2.6

34.71

33.36

umol/l

0.92

996

3182

Malignant neoplasm of digestive organs

1214

3094

3.12

259.70

3.1

2.6

37.23

32.87

umol/l

6.15

1117

2765

Other CVD (FINNGEN)

412

419

8.00

259.12

2.8

1.9

31.61

36.36

umol/l

1.12

368

362

Unspecified kidney failure

464

816

6.18

255.07

3.5

2.2

34.66

33.73

umol/l

0.22

418

707

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2110

5390

2.37

253.45

3.3

2.5

35.78

33.00

umol/l

4.41

1928

4853

Chronic hepatitis, not elsewhere classified

238

187

15.17

253.16

6.2

1.9

39.39

28.90

umol/l

5.33

233

165

Complications of medical and surgical care

1815

6896

2.42

251.80

2.9

2.6

33.05

33.65

umol/l

0.43

1641

6200

General examination and investigation of persons without complaint and reported diagnosis

1508

2814

2.85

248.59

3.2

2.3

31.69

34.85

umol/l

5.08

1393

2517

COPD (mode)

868

1877

3.75

248.39

2.1

2.6

32.56

34.78

umol/l

1.78

780

1674

Iron deficiency anaemia secondary to blood loss (chronic)

596

1330

4.77

248.29

4.1

2.4

35.07

32.99

umol/l

1.01

550

1183

Explicit bacterial Sepsis, including avohilmo

416

675

6.61

247.17

4.0

2.1

33.90

33.97

umol/l

0.01

382

605

Constipation

2166

6581

2.28

245.95

4.1

2.3

36.37

32.75

umol/l

6.30

1954

5941

Heart failure and coronary heart disease

1292

3191

2.95

244.50

2.5

31.62

34.26

umol/l

2.66

1158

2823

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1484

4482

2.68

244.14

3.2

2.4

35.14

32.80

umol/l

2.51

1358

3995

Focal epilepsy, strict definition

706

1813

4.12

244.10

2.9

31.20

34.03

umol/l

2.14

641

1638

Invasive ventilation

408

667

6.89

243.77

3.2

2.9

35.95

35.76

umol/l

0.03

373

606

Hypothyroidism (congenital or acquired)

408

254

9.19

243.66

3.3

2.8

34.31

35.07

umol/l

0.16

375

231

Acute pancreatitis (for exclusion)

741

1975

3.98

243.51

3.5

2.6

36.56

33.81

umol/l

1.79

684

1783

Open wound of head

1465

5395

2.62

241.70

2.8

2.7

33.55

33.91

umol/l

0.20

1297

4868

Explicit bacterial Sepsis

406

661

6.59

240.44

4.0

2.1

33.64

33.99

umol/l

0.07

372

593

Other viral hepatitis, including avohilmo

346

480

8.04

240.36

3.4

36.85

34.87

umol/l

0.63

323

448

Hypothyroidism and >3 levothyroxin purchases

401

250

9.18

239.58

3.3

2.8

34.42

35.15

umol/l

0.15

368

227

Hypothyroidism, levothyroxine purchases

401

250

9.18

239.58

3.3

2.8

34.42

35.15

umol/l

0.15

368

227

Diabetes mellitus

2178

5619

2.28

238.64

3.3

2.5

35.39

32.91

umol/l

3.91

2004

5066

Gastric ulcer

620

1472

4.45

238.17

4.1

2.1

38.20

32.30

umol/l

4.15

562

1287

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2233

6444

2.23

238.08

4.0

2.4

33.34

34.13

umol/l

0.61

2061

5825

Cardiac arrhythmias

1161

2451

3.10

237.69

2.9

2.7

32.15

35.46

umol/l

3.69

1055

2230

Other viral hepatitis

334

452

8.28

237.33

3.5

3.4

37.12

34.19

umol/l

1.13

311

420

Diabetes, varying definitions

2167

5620

2.28

237.00

3.3

2.5

35.53

32.90

umol/l

4.25

1993

5068

Implicit fungal Sepsis, including avohilmo

310

383

8.87

236.69

4.2

2.1

35.56

34.80

umol/l

0.10

275

348

Non-ischemic cardiomyopathy

940

2266

3.43

236.33

3.1

2.6

33.95

34.27

umol/l

0.12

856

2011

Type 2 diabetes

2092

5347

2.31

235.73

3.3

2.5

35.59

32.99

umol/l

3.99

1927

4811

Diabetes, insulin treatment (Kela reimbursement)

2251

6133

2.23

234.94

3.3

2.5

35.72

32.98

umol/l

4.65

2051

5507

Diseases of the myoneural junction and muscle

535

1155

5.02

233.56

3.1

2.8

31.14

34.61

umol/l

2.04

478

1045

Opioids

1946

4245

2.41

233.43

2.9

2.5

34.41

32.95

umol/l

1.22

1771

3826

Insulin, fast-acting or short human

1095

3806

2.99

232.33

3.6

2.6

34.87

33.72

umol/l

0.71

999

3424

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

329

450

8.03

230.58

2.5

3.4

35.71

33.94

umol/l

0.27

309

423

Heart failure and bmi 25plus

1066

2302

3.22

230.22

3.0

2.8

33.77

34.26

umol/l

0.21

974

2069

Any reimbursement code in KELA

1017

1482

3.50

230.08

3.2

2.6

35.92

33.94

umol/l

0.92

950

1344

Bacterial pneumoniae

1060

3137

3.06

229.55

2.6

2.7

30.92

34.42

umol/l

4.56

952

2787

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

600

555

5.52

228.50

3.3

2.3

35.25

35.09

umol/l

0.03

558

490

Other and unspecified myopathies

436

809

5.95

227.49

3.1

2.7

31.22

35.76

umol/l

2.11

389

722

Intestinal infectious diseases

2168

7543

2.18

226.35

3.1

2.6

32.66

33.82

umol/l

1.45

1965

6801

Endocrine, nutritional and metabolic diseases

1523

2920

2.68

224.25

3.2

2.5

35.51

33.32

umol/l

1.68

1396

2662

Persons encountering health services in other circumstances, wide

2505

6188

2.12

222.53

3.1

2.6

33.18

33.89

umol/l

0.58

2306

5519

Viral hepatitis, including avohilmo

362

579

6.88

219.76

3.4

3.2

36.78

36.33

umol/l

0.08

336

541

Atrial fibrillation and flutter with reimbursement

605

826

4.78

218.80

2.8

2.0

31.82

35.64

umol/l

1.56

549

730

Covid-19 confirmed case

1070

3795

2.92

218.23

2.9

2.5

30.03

33.65

umol/l

5.97

961

3393

COPD/asthma/ILD related infections

2000

4403

2.31

218.00

2.8

2.6

33.47

34.27

umol/l

0.51

1807

3972

COPD/asthma related infections

2000

4403

2.31

218.00

2.8

2.6

33.47

34.27

umol/l

0.51

1807

3972

Schizophrenia or delusion

876

2782

3.27

217.63

2.0

3.1

30.91

34.97

umol/l

5.41

782

2553

Viral hepatitis

350

547

7.07

217.45

3.4

3.3

37.04

36.27

umol/l

0.14

324

510

Schizophrenia, schizotypal and delusional disorders

877

2791

3.26

217.10

2.0

3.1

30.91

34.95

umol/l

5.42

783

2562

Focal epilepsy, mode (most common among epilepsy diagnosis)

647

1704

4.01

215.82

2.9

31.46

34.06

umol/l

1.74

582

1548

Fungal Sepsis

231

220

11.92

215.75

4.6

2.2

34.99

36.65

umol/l

0.15

210

202

Neurotic, stress-related and somatoform disorders

1947

6085

2.25

215.54

2.8

2.9

33.22

34.19

umol/l

0.98

1769

5538

Bacterial pneumonia, not elsewhere classified

998

2965

3.05

214.79

2.5

2.6

30.85

34.31

umol/l

4.25

897

2630

Gastrointestinal diseases

1030

1590

3.30

214.39

3.2

1.6

35.91

29.67

umol/l

6.93

953

1409

Diarrhoea and gastroenteritis of presumed infectious origin

1667

6500

2.34

214.21

3.3

2.6

32.75

33.87

umol/l

1.17

1516

5864

Diabetes medication

2198

6030

2.17

214.21

3.4

2.5

35.73

32.85

umol/l

5.00

2006

5436

Anxiety disorders

1963

6145

2.23

214.11

2.8

2.9

33.21

34.22

umol/l

1.04

1782

5595

Somnolence, stupor and coma

259

294

10.05

213.23

2.8

3.2

33.97

37.64

umol/l

0.48

235

271

Primary biliary cholangitis, wide definition

189

136

17.25

212.67

6.8

3.2

37.00

34.90

umol/l

0.41

184

120

Cardiovascular diseases

1078

1857

3.14

211.61

3.6

2.4

35.31

33.41

umol/l

1.02

1011

1697

Hard cardiovascular diseases

1878

4920

2.30

211.48

3.0

2.8

32.16

35.48

umol/l

6.54

1715

4454

All anxiety disorders

1371

4214

2.58

211.30

2.6

3.0

33.01

34.27

umol/l

1.10

1242

3868

Hypertension, essential

1575

3623

2.51

210.49

3.4

2.7

34.68

34.28

umol/l

0.20

1454

3296

Other and unspecified nonorganic psychotic disorders

587

1469

4.18

209.57

2.1

3.2

30.84

35.62

umol/l

4.42

520

1358

Streptococcal septicaemia, including avohilmo

374

649

6.23

208.23

4.2

2.7

34.37

33.98

umol/l

0.10

345

579

Complications of procedures, not elsewhere classified

1842

6781

2.23

207.87

3.0

2.6

33.46

33.86

umol/l

0.27

1676

6118

Early onset COPD, excluding more controls

595

1523

4.08

205.45

2.5

2.7

33.40

35.50

umol/l

1.24

537

1379

Asthma, unspecified (mode), excluding more controls

1020

2479

3.00

205.10

2.8

2.6

31.94

35.11

umol/l

3.62

936

2251

Pneumonitis due to solids and liquids

392

727

5.89

204.13

2.6

2.7

30.70

35.82

umol/l

2.33

353

642

Examination and observation for other reasons

1312

2804

2.70

202.02

3.3

2.3

33.47

34.85

umol/l

1.02

1193

2511

Streptococcal septicaemia

365

638

6.18

201.72

4.2

2.7

34.28

34.05

umol/l

0.06

336

570

Autoimmune hepatitis, wide definition

265

332

9.06

201.56

4.8

3.1

37.87

37.46

umol/l

0.05

253

295

Other anxiety disorders

1038

3148

2.87

201.09

2.5

3.1

32.30

34.38

umol/l

1.99

938

2902

Implicit fungal Sepsis

209

193

12.28

199.28

4.5

2.2

35.14

35.57

umol/l

0.03

189

176

Persons encountering health services in other circumstances

1019

3653

2.84

198.82

2.9

2.5

32.31

33.72

umol/l

1.30

957

3274

Alcohol-induced chronic pancreatitis

365

656

6.31

198.60

3.4

3.1

38.04

35.83

umol/l

0.53

333

598

Chronic viral hepatitis

275

370

8.33

196.46

3.3

3.6

37.68

34.52

umol/l

1.07

255

345

Other gastritis (incl. Duodenitis)

660

1881

3.67

195.45

4.3

2.2

38.15

32.71

umol/l

5.09

615

1664

Selective serotonin reuptake inhibitors

2032

4924

2.18

195.36

2.6

2.7

32.81

34.00

umol/l

0.98

1845

4438

Stroke, including SAH

1586

4972

2.35

195.05

2.3

2.7

30.75

34.43

umol/l

7.12

1407

4461

Medical observation and evaluation for suspected diseases and conditions

1404

2820

2.59

195.00

3.3

2.3

33.15

34.83

umol/l

1.15

1270

2523

Hyperkalaemia

295

432

7.56

194.97

4.2

2.5

34.69

34.30

umol/l

0.08

264

385

Extracorporeal dialysis

339

578

6.65

194.72

3.5

3.0

28.70

36.30

umol/l

3.55

314

525

Dyspnoea

2022

7036

2.11

194.48

2.8

2.7

32.44

33.98

umol/l

2.20

1840

6329

Hypertensive diseases

1571

3758

2.40

192.32

3.5

2.7

34.61

34.19

umol/l

0.22

1448

3427

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2127

6562

2.09

191.97

4.3

2.2

37.12

32.59

umol/l

12.07

1977

5863

Mental and behavioural disorders due to sedatives or hypnotics

312

492

6.96

191.95

2.5

3.4

37.06

34.95

umol/l

0.29

280

458

Cerebral cysts

290

426

7.56

191.23

6.7

2.9

42.30

33.96

umol/l

4.06

269

391

Traumatic subdural haemorrhage

447

895

4.92

191.22

3.0

2.3

32.88

36.10

umol/l

1.21

404

799

Acidosis

186

157

14.93

191.02

4.0

2.9

37.21

34.03

umol/l

0.69

174

143

Other diseases of pleura

1246

4372

2.56

191.02

2.8

2.5

32.94

33.43

umol/l

0.29

1134

3870

Falls/tendency to fall

2138

5119

2.12

190.99

3.0

2.7

33.76

34.11

umol/l

0.23

1929

4662

Hypertension

1566

3755

2.40

190.64

3.5

2.7

34.64

34.19

umol/l

0.24

1443

3425

Unspecified mental disorder

991

3635

2.81

189.50

2.1

2.9

32.02

34.05

umol/l

1.14

897

3314

Type 2 diabetes, definitions combined

1914

5208

2.17

188.44

3.5

2.5

36.42

32.99

umol/l

5.86

1761

4680

Personality disorders

704

2141

3.41

187.72

2.4

3.1

34.01

34.54

umol/l

0.14

638

1975

Other reaction to severe stress, and adjustment disorders

822

2734

3.09

187.50

3.1

3.0

33.32

34.68

umol/l

0.92

759

2518

Ulcer of lower limb, not elsewhere classified

529

1346

4.18

185.84

2.7

2.4

33.42

33.87

umol/l

0.12

467

1200

Disorders of adult personality and behaviour

730

2286

3.30

185.49

2.4

3.1

33.57

34.36

umol/l

0.24

661

2105

Abnormalities of breathing

1850

4910

2.19

184.81

3.0

2.7

33.57

34.11

umol/l

0.31

1701

4422

Type 2 diabetes, strict (exclude DM1)

1923

5284

2.15

184.81

3.5

2.5

36.43

33.02

umol/l

5.84

1768

4751

L04AA Selective immunosuppressants

674

2031

3.47

183.31

6.1

2.7

32.55

34.62

umol/l

1.30

639

1850

Headache

1156

3483

2.61

183.11

2.5

2.4

30.46

34.21

umol/l

6.82

1047

3143

Codes for special purposes

1294

5430

2.42

183.10

2.9

2.6

30.21

33.78

umol/l

7.54

1166

4882

First line medication for Crohn's disease

2276

6140

2.02

182.98

3.4

2.5

33.48

33.76

umol/l

0.20

2083

5518

Provisional assignment of new diseases of uncertain etiology

1292

5421

2.42

182.91

2.9

2.6

30.21

33.79

umol/l

7.54

1164

4874

Stroke, excluding SAH

1497

4777

2.32

179.41

2.3

2.6

30.58

34.32

umol/l

7.03

1329

4282

Nonorganic sleeping disorders, excluding more controls

447

1020

4.52

179.26

2.4

3.0

31.05

34.63

umol/l

2.40

411

940

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

596

1686

3.72

179.12

2.0

2.5

35.85

32.98

umol/l

1.56

537

1507

ILD medications: prednisolone, methylprednisolone, prednisone

2256

6340

2.01

178.95

3.6

2.4

33.24

33.84

umol/l

0.54

2067

5693

Recurrent or chronic depression

739

1549

3.38

178.19

3.1

2.8

35.17

34.94

umol/l

0.05

676

1427

Codeine

1713

4195

2.24

178.02

2.5

33.05

32.96

umol/l

0.04

1537

3779

Primary Sclerosing Cholangitis, IBD and UDCA required

172

143

14.67

177.46

8.4

3.0

34.65

33.15

umol/l

0.32

166

133

Pain, not elsewhere classified

596

1690

3.62

176.56

3.3

2.3

33.39

33.87

umol/l

0.19

540

1526

Specific personality disorders

617

1798

3.56

176.13

2.4

3.1

33.27

34.55

umol/l

0.36

557

1656

Kela-code for severe mental illness

900

3287

2.82

173.84

2.1

3.0

31.99

34.18

umol/l

1.14

821

3001

Asthma, unspecified (mode)

1049

2868

2.69

173.29

2.7

2.6

31.97

34.90

umol/l

3.31

958

2599

Abdominal and pelvic pain

1915

4574

2.13

173.28

3.2

2.2

33.87

32.47

umol/l

1.69

1753

4070

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1402

6161

2.28

173.01

3.0

2.6

32.90

33.50

umol/l

0.36

1260

5526

Type 2 diabetes, definitions combined, including avohilmo

1880

5227

2.11

172.25

3.4

2.5

36.32

32.97

umol/l

5.63

1733

4694

Encephalopathy

130

27.31

171.44

11.5

2.6

52.34

33.55

umol/l

6.81

121

Antihypertensive medication - note that there are other indications

1018

1898

2.85

169.82

3.4

2.4

34.18

33.17

umol/l

0.54

948

1738

Other pulmonary diagnosis

1438

3056

2.39

169.52

3.0

2.6

34.21

34.89

umol/l

0.31

1325

2772

Other (not insulin) diabetes medications

1961

5678

2.06

168.71

3.3

2.5

36.07

32.93

umol/l

5.21

1789

5105

Exposure to unspecified factor

2167

7639

1.96

168.25

2.9

2.7

33.19

33.69

umol/l

0.41

1947

6911

Neurological diseases

1612

3630

2.26

168.05

2.9

2.7

33.12

35.32

umol/l

2.33

1479

3308

Excluding asthma or asthma-COPD overlap

1434

3056

2.39

168.04

3.0

2.6

34.22

34.89

umol/l

0.30

1322

2772

ILD medications

2295

6434

1.95

166.61

3.7

2.4

33.41

33.79

umol/l

0.29

2105

5777

Mental and behavioural disorders due to opioids

202

230

9.86

165.48

2.3

3.5

37.67

34.53

umol/l

0.31

190

217

Superficial injury of head

656

2064

3.29

165.23

2.5

2.7

32.86

34.08

umol/l

0.50

591

1861

Infections of the skin and subcutaneous tissue

1398

6303

2.23

163.56

3.2

2.8

33.98

33.87

umol/l

0.05

1292

5715

Bacterial pneumonia (organism specified)

1117

4184

2.48

163.56

2.6

2.5

30.91

33.58

umol/l

3.18

1001

3723

COPD differential diagnosis

1424

3077

2.35

161.99

3.0

2.6

34.21

34.82

umol/l

0.27

1312

2794

ILD differential diagnosis

1424

3077

2.35

161.96

3.0

2.6

34.21

34.82

umol/l

0.27

1312

2794

Asthma, excluding more controls

1254

2626

2.49

161.55

2.8

2.7

32.19

35.12

umol/l

3.77

1154

2387

Other nutritional deficiencies

1464

6247

2.18

160.57

3.4

2.7

35.27

33.69

umol/l

1.51

1346

5681

Symptoms and signs involving the nervous and musculoskeletal systems

1355

6215

2.23

158.69

2.9

2.6

30.82

33.74

umol/l

5.04

1256

5571

Unspecified fall

1252

5455

2.31

158.43

2.8

2.7

33.44

umol/l

0.00

1134

4897

Certain infectious and parasitic diseases, including avohilmo

1302

2731

2.42

157.81

3.1

2.3

34.78

33.17

umol/l

0.89

1188

2467

Diseases of arteries, arterioles and capillaries

1569

5501

2.14

155.59

2.6

32.07

33.75

umol/l

1.75

1399

4920

Bipolar affective disorders

474

1260

3.90

155.19

2.4

3.0

32.74

34.26

umol/l

0.71

436

1158

Cardiac arrest

239

279

7.76

154.37

2.3

2.0

34.07

38.15

umol/l

0.52

212

242

Other degenerative diseases of the nervous system

660

1508

3.28

153.45

2.5

2.4

29.17

36.35

umol/l

8.41

578

1364

ILD medications: immunosuppressive drugs

1393

5901

2.18

152.08

4.7

2.4

33.18

34.09

umol/l

0.69

1309

5329

Lung diseases due to external agents

476

1300

3.87

151.03

2.5

2.6

31.80

34.28

umol/l

1.04

424

1157

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2192

6167

1.91

150.57

3.1

2.6

33.21

33.90

umol/l

0.66

2000

5503

Valvular heart disease excluding rheumatic fever

1057

3083

2.51

150.39

2.9

2.7

34.14

34.83

umol/l

0.34

972

2771

Cardiomyopathy

503

1427

3.68

150.02

2.5

2.7

32.14

35.37

umol/l

1.82

456

1284

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

278

498

6.05

150.00

2.6

3.2

30.67

34.46

umol/l

1.99

263

456

Injuries to the thorax

1159

5117

2.32

149.16

3.1

2.6

33.24

33.67

umol/l

0.25

1052

4600

Gout

835

2708

2.74

146.67

3.1

2.6

32.41

33.42

umol/l

0.60

762

2412

Disorders of mineral metabolism

307

615

5.34

145.96

3.9

2.9

34.99

35.09

umol/l

0.02

275

567

Emotionally unstable personality disorder

341

743

4.80

145.75

2.2

3.3

34.03

34.29

umol/l

0.03

306

704

Other bacterial intestinal infections

524

1563

3.50

144.75

3.2

2.4

32.51

33.82

umol/l

0.52

470

1405

Non-rheumatic valve diseases

1033

3036

2.49

144.36

2.9

2.7

34.27

34.82

umol/l

0.25

949

2729

Injuries to the abdomen, lower back, lumbar spine and pelvis

984

4066

2.45

142.40

3.0

2.6

34.34

33.22

umol/l

0.45

883

3641

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1503

6450

2.07

141.90

2.7

32.21

33.87

umol/l

1.91

1359

5771

All influenza

633

2135

3.06

141.62

3.0

2.8

31.22

34.94

umol/l

4.10

574

1907

Use of disulfiram, acamprosate or naltrexone

356

831

4.62

141.14

2.9

3.4

33.05

36.14

umol/l

1.09

324

767

Gout, FINNGEN

835

3252

2.64

140.70

3.1

2.5

32.41

33.78

umol/l

0.88

762

2875

Abnormal findings on examination of blood, without diagnosis

1212

5029

2.24

140.11

3.0

2.7

32.94

33.77

umol/l

0.60

1124

4505

Intestinal infectious diseases, including avohilmo, including avohilmo

2303

7118

1.83

138.43

3.0

2.6

32.78

33.84

umol/l

1.24

2088

6415

Ischaemic Stroke, excluding all haemorrhages

1334

4623

2.17

137.93

2.1

2.7

30.01

34.29

umol/l

8.25

1174

4137

Enterocolitis due to Clostridium difficile

373

916

4.32

137.55

3.1

2.6

31.91

34.50

umol/l

0.90

339

823

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1277

6042

2.15

137.34

2.9

2.6

32.44

33.51

umol/l

0.78

1147

5438

Acute peritonitis

281

554

5.55

137.03

4.5

2.9

36.08

36.33

umol/l

0.04

268

498

Neurological diseases, wide definition

542

732

3.79

136.81

3.0

2.9

33.86

37.25

umol/l

1.68

509

683

Asthma

1308

3032

2.26

136.78

2.8

2.6

32.31

34.92

umol/l

3.18

1199

2751

severe traumatic brain injury, does not include concussion

646

2260

2.97

136.12

3.0

2.6

33.32

33.44

umol/l

0.04

588

1996

Other disorders of skin and subcutaneous tissue

1562

6691

2.01

135.17

3.0

2.5

31.88

33.76

umol/l

2.35

1392

6017

Biguanides

1873

5966

1.92

134.42

3.2

2.5

35.65

32.96

umol/l

4.04

1700

5362

Other respiratory disorders and diseases

588

1982

3.09

132.56

2.6

2.5

33.24

33.37

umol/l

0.04

544

1747

Other diseases of the respiratory system

588

1982

3.09

132.56

2.6

2.5

33.24

33.37

umol/l

0.04

544

1747

Sequelae of cerebrovascular disease

886

3087

2.52

132.43

2.0

2.4

29.41

33.94

umol/l

7.00

782

2739

Persons encountering health services for specific procedures, not carried out

279

561

5.26

131.69

3.4

2.9

37.10

35.47

umol/l

0.31

248

520

367

916

4.17

131.46

3.1

2.8

29.99

34.32

umol/l

3.74

345

838

Autoimmune diseases excluding thyroid diseases

2075

6130

1.86

131.26

3.0

2.7

32.39

34.03

umol/l

2.20

1888

5513

Oral corticosteroids

2086

6738

1.84

130.00

2.9

2.6

32.66

34.09

umol/l

1.83

1911

6047

Supplementary factors related to causes of morbidity and mortality classified elsewhere

778

3061

2.62

129.83

3.2

2.7

33.08

33.89

umol/l

0.42

718

2770

Non-selective monoamine reuptake inhibitors

774

2898

2.62

129.69

2.7

2.6

32.58

33.94

umol/l

0.98

705

2608

Symptoms and signs involving the urinary system

1641

6436

1.96

129.48

2.9

2.7

32.64

33.81

umol/l

1.09

1460

5808

Haemorrhage from respiratory passages

852

3073

2.52

128.43

3.3

2.5

34.45

33.58

umol/l

0.47

765

2734

Other diseases of intestines

2039

6213

1.85

128.38

3.3

2.6

33.98

33.60

umol/l

0.22

1853

5617

COPD

1120

4168

2.24

126.94

2.2

2.6

32.29

33.66

umol/l

1.15

998

3711

Portal vein thrombosis

129

116

13.73

126.93

5.9

2.6

46.37

31.68

umol/l

5.71

122

104

Autoimmune diseases excluding thyroid diseases, strict definition

2007

5955

1.86

126.79

3.0

2.6

32.46

34.08

umol/l

2.09

1829

5353

Other CVD

571

1941

3.06

126.76

2.8

2.4

31.51

32.97

umol/l

0.73

503

1709

Cholelithiasis, broad definition with cholecystitis

1655

5731

1.95

126.62

2.9

2.5

33.73

32.94

umol/l

0.60

1519

5110

Alcohol-induced acute pancreatitis

216

363

6.83

126.46

3.9

3.1

38.66

36.64

umol/l

0.28

203

329

Polyneuropathies and other disorders of the peripheral nervous system

626

2252

2.90

125.51

3.8

2.6

32.75

34.05

umol/l

0.61

566

2018

Toxic liver disease

109

17.54

125.20

4.6

2.2

36.76

30.04

umol/l

0.92

103

Asthma (only as main-diagnosis), excluding more controls

1091

2626

2.33

125.20

2.6

2.7

32.04

35.12

umol/l

3.55

989

2387

Nonalcoholic fatty liver disease

354

900

4.18

124.78

5.0

3.2

40.44

35.52

umol/l

2.14

336

835

Gout, idiopatic and unspecified

725

2824

2.67

124.37

3.1

2.4

32.51

33.82

umol/l

0.74

662

2498

Bacterial intestinal infections, IBD co-morbidities

518

1684

3.20

124.33

3.2

2.6

32.72

33.51

umol/l

0.27

464

1517

Other disorders of glucose regulation and pancreatic internal secretion

313

728

4.59

124.31

3.2

3.1

32.81

36.85

umol/l

1.16

282

661

Fracture of rib(s), sternum and thoracic spine

806

3304

2.52

123.55

3.2

2.7

32.90

33.94

umol/l

0.59

726

2966

Inflammatory bowel disease treatment related agents

2203

6929

1.79

123.28

3.1

2.7

32.45

34.00

umol/l

2.25

2023

6222

Hypertensive heart and/or renal disease

622

1573

2.97

122.79

2.2

2.3

31.46

33.48

umol/l

0.99

559

1391

Hypothyroidism, drug reimbursement

185

150

8.78

122.16

2.6

2.9

34.23

37.10

umol/l

0.42

165

136

Peripheral artery disease

1047

3736

2.27

122.08

2.2

2.4

31.56

33.09

umol/l

1.05

915

3306

Intestinal stricture

778

3164

2.53

121.27

3.0

2.6

32.99

33.47

umol/l

0.19

703

2829

Cutaneous abscess, furuncle and carbuncle

656

2455

2.76

121.23

3.2

2.8

34.05

34.73

umol/l

0.28

611

2234

Other chronic obstructive pulmonary disease

1072

4032

2.23

120.86

2.2

2.5

32.34

33.55

umol/l

0.95

955

3585

Other bacterial intestinal infections, including avohilmo

587

2077

2.92

120.75

3.1

2.6

32.33

33.64

umol/l

0.62

525

1874

Gout, unspecified

611

2227

2.86

119.70

3.3

2.4

32.55

33.85

umol/l

0.62

556

1962

Degeneration of nervous system due to alcohol

167

229

8.86

119.54

4.5

3.1

35.81

34.04

umol/l

0.36

155

204

Degeneration of the brain due to alcohol

167

229

8.86

119.54

4.5

3.1

35.81

33.63

umol/l

0.47

155

206

Purpura and other haemorrhagic conditions

419

1229

3.58

119.36

4.9

2.7

39.82

33.87

umol/l

3.26

396

1113

Pulmonary heart disease, diseases of pulmonary circulation

778

3186

2.51

119.32

2.6

2.5

32.04

33.73

umol/l

1.03

710

2833

Other chronic obstructive pulmonary disease, including avohilmo

1259

5079

2.08

119.31

2.3

2.6

32.33

33.52

umol/l

1.06

1125

4537

Thrombocytopenia, unspecified

285

638

4.82

119.19

5.5

2.7

41.16

36.47

umol/l

1.24

267

573

Glomerular disorders in diseases classified elsewhere

389

1093

3.77

118.73

2.5

2.9

28.05

35.56

umol/l

6.25

354

987

Assault

392

1103

3.71

118.68

2.7

3.3

33.94

35.44

umol/l

0.53

366

1029

Hypoglycaemia, other or unspecified

270

580

5.02

118.68

3.4

3.1

33.71

35.77

umol/l

0.38

241

526

COPD related to multimorbidity

983

3726

2.29

118.54

2.2

2.5

32.06

33.19

umol/l

0.82

876

3300

Disorders of calcium metabolism

231

434

5.71

118.21

3.4

2.9

34.10

35.34

umol/l

0.26

204

393

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1985

7165

1.80

117.78

3.2

2.6

33.14

33.84

umol/l

0.64

1812

6453

Diseases of peritoneum

337

862

4.15

117.72

4.2

2.8

35.43

umol/l

0.00

320

775

Duodenal ulcer

352

928

4.00

117.57

4.0

2.1

38.45

33.53

umol/l

1.91

309

817

Diagnoses used for exclusion with ILD

654

2492

2.71

116.83

2.6

2.7

31.78

34.03

umol/l

1.41

591

2226

Coagulation defects, purpura and other haemorrhagic conditions

527

1800

3.04

115.99

4.7

2.7

38.78

33.49

umol/l

3.82

490

1629

Paralytic ileus and intestinal obstruction

649

2478

2.70

115.03

2.8

2.4

32.47

33.07

umol/l

0.23

581

2202

Glomerular diseases

524

1796

3.05

114.99

3.0

2.9

28.86

34.64

umol/l

6.26

480

1620

Osteopathies and chondropathies

1198

5395

2.07

114.54

3.2

2.6

32.65

33.76

umol/l

0.93

1067

4860

Obesity and other hyperalimentation

1281

6092

2.01

114.13

3.3

2.7

35.88

33.60

umol/l

2.37

1174

5544

Hypotension

501

1685

3.10

113.49

2.5

2.4

30.90

32.94

umol/l

1.08

438

1480

Other neurological diseases

1520

6259

1.92

113.42

3.1

2.5

32.66

33.53

umol/l

0.66

1362

5607

Secondary hypertension

208

359

5.98

113.26

3.2

2.1

27.53

35.49

umol/l

2.15

187

320

Other disorders of urethra and urinary system

1375

4872

1.99

113.16

3.0

2.5

32.25

33.62

umol/l

1.23

1231

4386

Ischemic heart diseases

1666

5331

1.89

113.07

3.1

2.8

32.54

35.04

umol/l

3.72

1518

4807

Obesity

1273

6075

2.01

112.80

3.4

2.8

35.92

33.62

umol/l

2.39

1169

5530

Paroxysmal tachycardia

399

939

3.61

112.46

2.8

2.1

33.55

34.54

umol/l

0.25

365

838

Gout, strict definition

556

1998

2.91

112.09

3.0

2.4

31.69

33.63

umol/l

1.16

505

1749

Primary biliary cholangitis (PBC)

125

128

11.25

111.37

5.3

2.7

33.22

33.24

umol/l

0.00

120

110

Fracture of skull and facial bones

527

1838

2.96

111.35

2.8

2.9

34.31

35.20

umol/l

0.32

487

1682

COPD, early/later onset

1077

4313

2.15

110.98

2.2

2.5

32.32

33.16

umol/l

0.58

958

3836

Pain in throat and chest

1545

4816

1.92

110.97

2.8

2.7

32.81

34.09

umol/l

1.20

1403

4334

Decubitus ulcer and pressure area

247

523

5.09

110.53

2.3

2.4

31.18

33.14

umol/l

0.49

220

463

Presence of cardiac and vascular implants and grafts

1050

3618

2.19

110.19

2.2

2.3

30.49

33.73

umol/l

4.57

920

3223

Asthma (mode)

1221

3077

2.11

109.66

2.9

2.6

32.34

34.82

umol/l

2.80

1121

2794

Episodal and paroxysmal disorders

1990

5716

1.79

109.45

2.7

32.35

34.41

umol/l

3.04

1805

5150

Disorders of lipoprotein metabolism and other lipidaemias

1493

4768

1.93

108.85

2.7

32.50

34.38

umol/l

1.91

1317

4300

Codeine or tramadol medication

2099

6603

1.75

108.79

2.4

2.8

33.13

33.79

umol/l

0.46

1883

5970

Other functional intestinal disorders

984

4167

2.19

108.77

2.4

2.5

31.62

33.14

umol/l

1.25

865

3739

Obesity due to excess calories

979

4608

2.17

107.60

3.3

2.8

36.08

33.57

umol/l

2.26

906

4191

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

606

2248

2.70

106.69

1.9

2.6

37.69

32.85

umol/l

3.83

547

2009

Asthma-related pneumonia or sepsis

844

3747

2.30

106.57

2.6

2.5

31.12

33.43

umol/l

2.41

766

3334

Asthma, hospital admissions 3, pneumonia

844

3747

2.30

106.57

2.6

2.5

31.12

33.43

umol/l

2.41

766

3334

COPD, hospital admission 2, with asthma infections

807

3009

2.38

106.13

2.3

2.4

31.36

33.49

umol/l

1.73

715

2651

Asthma-related pneumonia

842

3741

2.30

106.13

2.6

2.5

31.12

33.44

umol/l

2.42

764

3328

Factors influencing health status and contact with health services

525

831

3.22

106.01

3.0

2.1

36.00

35.79

umol/l

0.03

478

745

Early onset COPD

595

2275

2.71

105.96

2.5

2.9

33.40

34.84

umol/l

0.75

537

2051

Autoimmune diseases

2091

6161

1.74

105.74

2.9

2.7

33.05

34.06

umol/l

0.97

1914

5541

Pain in limb

1669

5872

1.83

104.56

3.0

2.7

33.11

34.11

umol/l

0.64

1501

5307

Mental and behavioural disorders due to use of other stimulants, including caffeine

132

157

9.29

104.29

2.3

4.1

34.76

38.06

umol/l

0.72

127

152

COPD-related respiratory insufficiency

377

1131

3.51

103.97

2.4

2.6

31.43

34.31

umol/l

1.37

339

1003

Cardiomyopathy (excluding other)

354

1020

3.63

103.54

2.6

2.7

30.95

35.28

umol/l

2.21

321

909

COPD, hospital admissions

1050

4295

2.11

103.42

2.2

2.5

32.28

33.17

umol/l

0.61

933

3817

Cholelithiasis

1521

5633

1.87

103.12

2.8

2.5

33.67

32.97

umol/l

0.48

1394

5020

Respiratory insufficiency

240

521

4.83

102.92

2.3

2.6

34.29

35.53

umol/l

0.24

224

453

Speech and linguistic disorders, excluding more controls

197

331

5.81

102.81

3.1

3.2

34.49

34.14

umol/l

0.05

182

311

Symptoms and signs concerning food and fluid intake

274

660

4.32

102.77

2.5

2.4

32.01

32.49

umol/l

0.15

244

598

Other and unspecified polyneuropathies, also in other diseases

532

1955

2.83

102.56

3.9

2.5

32.22

33.79

umol/l

0.76

482

1735

Cholangitis (primary sclerosing, PSC), with reimbursement 202

125

144

10.25

102.55

6.4

3.2

33.87

34.30

umol/l

0.07

118

131

Major coronary heart disease event

1675

5572

1.83

102.29

3.1

2.7

32.36

34.93

umol/l

3.92

1521

5021

Polyarthropathies

1393

4722

1.92

101.71

2.9

2.7

32.24

34.03

umol/l

2.01

1281

4264

Hypertensive Heart Disease

545

1486

2.86

101.70

2.3

31.85

33.43

umol/l

0.64

489

1310

Parasetamol

1290

3276

2.02

101.67

2.6

3.3

33.38

35.74

umol/l

1.68

1183

2990

Chronic gastritis

594

2311

2.64

101.49

3.8

2.0

36.22

32.08

umol/l

2.92

526

2024

Malignant neoplasm, including Hilmo

1615

5177

1.84

101.08

3.2

2.9

35.33

33.25

umol/l

2.51

1486

4703

Asthma (only as main-diagnosis)

1121

3032

2.09

100.26

2.6

32.08

34.92

umol/l

3.24

1013

2751

Malignant neoplasm, wide definition

1617

5196

1.84

100.24

3.1

2.9

35.31

33.28

umol/l

2.41

1487

4721

Other external causes of accidental injury

1378

3573

1.96

99.74

2.9

2.6

33.68

33.90

umol/l

0.11

1252

3239

Atherosclerosis, excluding cerebral and coronary sclerosis

947

3503

2.17

99.61

2.0

2.4

30.51

33.16

umol/l

2.39

832

3093

Symptoms and signs involving the circulatory and respiratory systems

1752

4920

1.80

99.46

3.0

2.7

33.73

34.10

umol/l

0.19

1601

4429

Fracture of lower leg, including ankle

1138

5715

1.99

99.14

2.9

2.7

35.46

33.42

umol/l

1.90

1026

5162

COPD, hospital admissions 3, with asthma pneumonia sepsis

690

2465

2.47

98.88

2.1

2.4

30.85

33.07

umol/l

1.65

614

2154

Type 1 diabetes

549

2082

2.70

98.38

2.4

2.5

31.19

33.67

umol/l

1.58

497

1881

Dizziness and giddiness

1356

5653

1.89

98.08

2.5

2.7

31.72

34.39

umol/l

3.83

1204

5132

Cardiomyopathies, Primary/intrinsic

341

995

3.58

97.87

2.6

2.7

30.73

36.12

umol/l

2.98

310

885

Other soft tissue disorders, not elsewhere classified

1819

5954

1.76

97.63

3.1

2.6

33.07

34.12

umol/l

0.74

1641

5380

Percutaneous Coronary Intervention

1556

5230

1.84

97.35

3.1

2.8

32.01

34.95

umol/l

5.12

1413

4716

Accidents

1367

3573

1.94

96.71

2.8

2.6

34.21

33.90

umol/l

0.12

1243

3239

Bronchitis

2027

7259

1.69

96.34

2.9

2.6

34.01

33.43

umol/l

0.37

1837

6529

Other acute lower respiratory infections

1125

5507

1.98

96.16

2.7

2.6

34.14

33.32

umol/l

0.46

1027

4934

Viral pneumonia

342

1011

3.52

95.96

3.9

3.0

31.12

35.00

umol/l

2.43

309

911

Fentanyl

276

705

4.07

95.68

2.5

2.2

34.91

32.97

umol/l

0.24

239

623

Retention of urine

846

3142

2.23

95.43

2.5

2.4

31.02

33.27

umol/l

1.75

746

2808

Malignant neoplasm

1567

5113

1.82

94.51

3.1

2.9

35.38

33.32

umol/l

2.40

1441

4642

Later onset COPD, excluding more controls

457

1188

3.02

93.96

1.9

2.1

31.04

33.70

umol/l

1.52

403

1040

Coronary revascularization (ANGIO or CABG)

1544

5232

1.82

93.71

3.2

2.8

32.09

34.96

umol/l

4.85

1403

4718

Pacemaker

838

3631

2.20

93.62

2.3

31.50

32.90

umol/l

0.90

741

3183

Used for control exclusion in common control thyroid runs

1946

5779

1.72

93.44

3.0

2.6

33.16

34.15

umol/l

0.87

1786

5200

Amputation

319

924

3.63

92.86

2.6

30.57

34.34

umol/l

1.57

273

812

Malignant neoplasm

1556

5102

1.81

92.35

3.1

2.9

35.42

33.32

umol/l

2.45

1430

4632

External causes of morbidity and mortality

1042

2519

2.10

91.22

2.9

2.6

34.42

34.08

umol/l

0.11

951

2290

Transport accidents

829

3199

2.19

91.08

2.7

33.48

34.06

umol/l

0.18

756

2914

Solid cancers, including Hilmo

1552

5083

1.80

90.80

3.1

2.9

35.08

33.30

umol/l

1.86

1423

4614

Other special examinations and investigations of persons without complaint or reported diagnosis

1119

2820

2.04

90.72

3.2

2.3

32.42

34.83

umol/l

2.42

1032

2523

Fracture of lumbar spine and pelvis

538

2108

2.62

90.33

2.9

2.4

33.97

32.68

umol/l

0.54

470

1881

Other or unspecified ileus, impaction or obstruction

463

1689

2.83

90.10

2.9

2.4

32.58

32.87

umol/l

0.09

413

1506

Cholecystitis

358

1133

3.28

89.95

3.1

2.3

33.81

33.63

umol/l

0.04

329

1006

Endocarditis

152

250

6.65

89.91

2.5

3.2

34.20

38.16

umol/l

0.50

144

229

Diabetic nephropathy, excluding more controls

453

1305

2.96

89.82

2.5

2.9

30.31

34.67

umol/l

3.28

407

1177

Pulmonary embolism

669

2911

2.36

89.64

2.6

31.40

33.92

umol/l

1.96

609

2593

Inflammatory diseases of the central nervous system

263

687

4.05

89.28

2.6

3.0

29.44

36.45

umol/l

3.85

240

628

Other symptoms and signs involving the nervous and musculoskeletal systems

847

4071

2.12

88.27

2.8

2.7

30.68

33.79

umol/l

3.69

803

3669

Other diseases of pancreas

263

693

4.02

88.23

3.4

2.6

37.10

36.21

umol/l

0.16

239

617

2025

6219

1.67

87.68

2.7

2.6

33.71

33.53

umol/l

0.09

1831

5576

Pulmonary heart disease

669

2942

2.33

87.46

2.6

31.40

33.92

umol/l

1.98

609

2620

Chronic ulcer of skin, not elsewhere classified

238

588

4.31

87.45

2.9

2.5

33.44

35.33

umol/l

0.35

212

525

Type of accident

650

2824

2.36

87.37

3.2

2.7

33.00

33.80

umol/l

0.37

602

2551

Solid cancers

1508

4992

1.79

87.06

3.0

2.9

35.52

33.33

umol/l

2.54

1380

4532

Autoimmune diseases related-to ILD

1585

7735

1.73

87.04

3.1

2.6

32.02

33.96

umol/l

2.91

1448

6953

Any dementia, excluding more controls

705

2108

2.35

86.60

1.8

2.0

26.71

33.25

umol/l

10.67

580

1852

Preparatory care for dialysis

191

403

5.22

86.55

2.1

3.2

27.81

36.62

umol/l

2.63

169

362

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

236

370

4.62

86.13

2.8

2.4

32.35

40.62

umol/l

3.12

225

339

Diseases of the respiratory system

1024

2515

2.06

86.12

2.8

2.6

34.38

34.31

umol/l

0.02

932

2284

Emergency coronary revascularization (for ACS)

1665

5876

1.73

86.03

3.1

2.7

32.06

34.72

umol/l

4.56

1508

5282

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

263

705

3.92

85.86

2.7

32.87

34.82

umol/l

0.46

242

640

Major coronary heart disease event excluding revascularizations

1234

4382

1.89

85.83

2.4

2.7

31.58

34.71

umol/l

4.16

1091

3923

Other specified and unspecified personality disorders

248

639

4.07

85.54

2.7

3.3

36.64

34.45

umol/l

0.25

217

598

Haemorrhage, not elsewhere classified

139

219

6.82

85.40

2.8

2.3

34.68

31.96

umol/l

0.65

129

191

Dysphagia

505

1975

2.62

85.31

2.5

1.9

29.40

31.64

umol/l

1.66

449

1742

Genitourinary diseases

1115

2845

1.99

85.07

3.5

2.6

34.89

35.43

umol/l

0.27

1015

2606

ILD medications: azathioprine

363

1202

3.13

84.44

3.6

2.5

32.25

34.89

umol/l

1.30

340

1086

Blood alcohol or alcohol intoxication level

123

174

7.93

84.34

3.3

3.5

33.87

35.40

umol/l

0.26

113

159

Nontraumatic intracranial haemmorrhage

456

1709

2.75

84.17

2.6

32.76

34.45

umol/l

0.65

411

1516

Pure hypercholesterolaemia

1308

4575

1.84

83.38

2.6

32.08

34.38

umol/l

2.35

1160

4122

Vocal cord dysfunction

210

412

4.58

83.27

2.7

2.5

34.86

36.68

umol/l

0.36

192

379

Panic disorder

301

898

3.45

82.88

2.4

3.0

31.87

35.17

umol/l

1.51

274

837

Malignant neoplasm of pancreas, including Hilmo

262

720

3.83

82.62

1.7

2.5

35.96

33.99

umol/l

0.44

236

639

Gastro-oesophageal reflux disease

1225

5703

1.84

82.14

2.8

2.3

32.21

32.71

umol/l

0.34

1094

5122

Myocardial infarction

1032

3729

1.97

82.08

2.4

2.7

31.36

34.61

umol/l

4.05

921

3331

Hyperkinetic disorders, excluding more controls

185

356

4.95

82.06

3.3

3.0

34.04

32.87

umol/l

0.24

170

336

Any event in cancer register

1610

5505

1.73

81.88

3.1

2.9

35.18

33.38

umol/l

1.97

1476

5012

Diseases of the skin and subcutaneous tissue

1751

5221

1.70

81.37

2.9

2.6

32.67

34.30

umol/l

1.75

1580

4710

Dialysis

163

316

5.64

81.20

2.4

2.9

25.01

33.86

umol/l

5.58

149

291

Elevated blood glucose level

259

715

3.82

81.19

3.8

3.1

35.69

35.58

umol/l

0.02

249

651

Asthma, hospital admission 2, infections

1164

6252

1.84

80.60

2.7

32.08

33.88

umol/l

1.89

1060

5623

Asthma-related infections

1164

6252

1.84

80.60

2.7

32.08

33.88

umol/l

1.89

1060

5623

Pleural effusion

401

1444

2.88

80.37

3.3

2.5

33.18

33.54

umol/l

0.10

367

1264

Low back pain

1445

5624

1.76

80.11

3.0

2.7

33.31

34.12

umol/l

0.54

1309

5111

Persons encountering health services for examination and investigation

1089

2820

1.96

79.56

3.2

2.3

34.31

34.83

umol/l

0.18

1008

2523

Vascular disorders of the intestines

224

567

4.18

79.47

3.8

2.2

36.04

33.01

umol/l

0.76

203

503

Osteoporosis

560

2170

2.43

79.26

3.6

2.5

32.25

33.22

umol/l

0.43

488

1928

Kidney transplant status

201

473

4.59

79.20

4.0

3.5

29.16

37.99

umol/l

3.48

188

439

Peripheral artery operations in Hilmo

343

1143

3.12

79.07

2.6

2.5

30.83

33.79

umol/l

1.29

294

1004

Other disorders of skin and subcutaneous tissue, not elsewhere classified

357

1218

3.04

78.93

2.8

2.6

31.82

34.05

umol/l

0.79

318

1103

Missing teeth due to accident, extraction or parodontitis

1257

6352

1.80

78.73

3.1

2.6

32.97

33.59

umol/l

0.43

1125

5702

Azathioprine

363

1257

2.99

78.05

3.6

2.9

32.25

35.74

umol/l

1.98

340

1137

Fracture of shoulder and upper arm

769

3731

2.10

78.05

2.9

2.7

33.12

33.64

umol/l

0.24

688

3352

Acute bronchitis

829

4053

2.04

77.97

2.6

34.18

33.08

umol/l

0.56

753

3612

Coronary atherosclerosis

1253

4392

1.83

77.90

2.6

2.7

31.80

34.92

umol/l

4.20

1131

3939

Peripheral arterial reconstruction

430

1633

2.73

77.74

1.8

2.4

30.36

33.44

umol/l

1.49

374

1420

Disorders of other endocrine glands

852

4228

2.02

77.61

2.7

2.8

31.87

33.59

umol/l

1.43

767

3821

Other diseases of urinary system

1793

6163

1.65

76.50

2.9

2.7

32.08

34.14

umol/l

2.88

1613

5588

Viral encephalitis, not elsewhere classified/unspecified

115

170

7.75

76.18

1.8

3.2

27.73

33.57

umol/l

1.46

155

Schizophrenia

381

1379

2.86

75.50

1.7

3.2

30.30

36.21

umol/l

4.95

343

1273

Persistent mood disorders

389

1423

2.81

75.22

3.0

2.9

31.92

33.96

umol/l

0.97

351

1291

Other and unspecified drugs and medicaments

249

705

3.71

75.16

2.8

2.9

32.82

35.32

umol/l

0.62

228

640

KRA_PSY_EATING, excluding more controls

126

200

6.40

74.95

2.7

3.0

29.43

33.31

umol/l

0.80

110

190

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

115

173

7.59

74.92

1.8

3.2

27.73

33.44

umol/l

1.41

158

Traumatic subarachnoid haemorrhage

126

206

6.54

74.60

4.3

2.6

33.56

39.79

umol/l

0.71

117

185

Focal brain injury

176

388

4.75

74.43

2.5

2.9

32.21

38.26

umol/l

1.43

170

351

Ischaemic heart disease, wide definition

1457

5269

1.73

74.41

2.8

2.9

32.07

34.76

umol/l

3.85

1316

4758

Venous thromboembolism

1077

5722

1.84

74.34

2.7

2.6

31.80

33.64

umol/l

1.90

976

5108

Cellulitis

513

2162

2.44

74.17

3.4

2.8

34.40

34.69

umol/l

0.09

473

1962

Phobic anxiety disorders

265

788

3.45

73.06

2.6

3.2

32.38

35.63

umol/l

1.10

240

736

Neoplasms

1282

3782

1.80

73.02

3.5

2.7

35.45

32.96

umol/l

2.81

1182

3449

Other symptoms and signs involving general sensations and perceptions

144

275

5.60

72.54

2.0

3.4

29.84

35.04

umol/l

2.00

122

252

Benign neoplasm of colon, rectum, anus and anal canal

1271

6230

1.75

72.46

3.4

2.5

35.02

33.20

umol/l

1.61

1133

5578

Vitamin deficiency, wide

164

351

4.98

72.41

4.5

3.0

34.81

33.89

umol/l

0.15

156

314

Vitamin deficiency

164

351

4.98

72.41

4.5

3.0

34.81

33.89

umol/l

0.15

156

314

Malignant neoplasm of pancreas

218

579

3.97

72.35

1.7

2.4

35.35

34.48

umol/l

0.14

198

512

DVT of lower extremities and pulmonary embolism

855

4428

1.96

71.53

2.7

2.6

31.38

33.59

umol/l

2.04

777

3931

Sulfonylureas

695

2627

2.15

71.49

2.6

2.0

34.58

31.42

umol/l

2.18

624

2287

Alcoholic gastritis

123

9.09

71.03

4.0

2.7

33.05

41.99

umol/l

0.67

114

Other and unspecified mood [affective] disorders

166

362

4.76

71.01

2.7

3.3

33.76

33.95

umol/l

0.03

152

339

Pain (limb, back, neck, head abdominally)

1274

3603

1.79

70.97

3.0

2.5

34.51

33.99

umol/l

0.21

1150

3261

Chronic lower respiratory diseases

2131

7276

1.56

70.61

2.6

2.8

32.61

34.01

umol/l

1.89

1946

6565

Cardiomyopathy, other and unspecified

214

573

3.92

70.07

2.5

2.9

33.12

37.14

umol/l

1.05

197

514

Nonorganic sleeping disorders

447

1818

2.52

69.75

2.4

3.0

31.05

34.73

umol/l

2.70

411

1676

Conduction disorders

576

2060

2.29

69.38

2.1

2.6

31.87

34.09

umol/l

1.14

504

1841

Sequelae of external causes of morbidity and mortality

563

2543

2.27

69.23

2.5

2.8

32.60

33.89

umol/l

0.66

507

2285

Noninfective enteritis and colitis

897

4793

1.90

68.75

3.2

2.7

32.10

33.65

umol/l

1.40

832

4339

Benign neoplasm: Colon

1099

5857

1.79

68.69

3.4

2.5

35.05

33.19

umol/l

1.46

984

5239

Type 1 diabetes, wide definition, subgroup 1

406

1598

2.60

67.68

2.2

2.5

28.60

33.36

umol/l

3.99

364

1444

Other diseases of blood and blood-forming organs, wide

496

2148

2.37

67.55

3.7

2.7

35.61

33.80

umol/l

0.76

454

1936

Acute and transient psychotic disorders

278

902

3.20

67.18

1.9

3.3

30.33

36.06

umol/l

3.62

252

840

Mixed and other personality disorders

203

543

3.90

66.46

2.5

3.4

38.77

34.53

umol/l

0.47

182

511

Other mental disorders due to brain damage and dysfunction and to physical disease

293

988

3.08

66.31

2.7

2.5

30.36

35.38

umol/l

2.41

253

885

Abnormal involuntary movements

333

1204

2.86

66.31

2.9

2.8

30.26

34.66

umol/l

2.67

303

1092

Candidiasis

325

1165

2.88

65.63

4.0

2.7

35.68

34.51

umol/l

0.30

295

1065

Adjustment and management of implanted device

376

1451

2.66

65.61

2.2

2.3

32.99

33.64

umol/l

0.16

329

1258

Other and unspecified injuries of head

205

558

3.85

65.52

2.7

2.8

29.89

35.92

umol/l

2.16

186

504

Injuries to the hip and thigh

968

4812

1.83

65.04

2.6

2.5

32.55

33.30

umol/l

0.41

845

4296

Liquid cancers, including Hilmo

708

3123

2.04

64.89

2.5

2.6

34.70

32.84

umol/l

1.02

640

2801

Fracture of femur

575

2405

2.20

64.69

2.5

2.3

31.28

33.05

umol/l

0.92

488

2106

Speech disturbances, not elsewhere classified

253

798

3.32

64.42

2.4

2.7

30.12

35.29

umol/l

2.43

227

710

Cytomegalovirus infection, IBD co-morbidity

111

188

6.61

64.27

5.7

3.1

31.48

34.40

umol/l

0.57

103

170

Chronic apical periodontitis

1912

6953

1.56

64.23

2.9

2.6

33.69

33.49

umol/l

0.13

1724

6268

Generalized anxiety disorder

288

973

3.02

64.21

2.6

3.1

33.06

34.77

umol/l

0.47

256

901

Other dialysis

139

290

5.31

64.08

2.2

3.4

24.19

34.13

umol/l

6.21

128

263

Mycoses

584

2764

2.16

63.80

3.4

2.7

34.03

33.88

umol/l

0.05

521

2506

Disorders of thyroid, IBD co-morbidities

251

503

3.47

63.54

2.6

31.28

38.74

umol/l

3.53

221

469

Alcohol abuse counselling and surveillance

133

8.01

63.51

3.6

3.9

33.71

36.16

umol/l

0.42

125

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

489

2131

2.31

63.26

3.2

2.9

31.93

33.98

umol/l

1.44

448

1965

Valvular operations

326

1195

2.81

63.12

2.3

2.6

33.23

35.73

umol/l

1.00

301

1062

Chronic periodontitis, complicated

1111

6337

1.73

62.80

2.7

2.8

35.42

33.67

umol/l

0.93

1011

5725

Cytomegaloviral disease

112

196

6.36

62.66

5.7

3.1

31.36

33.69

umol/l

0.43

104

177

Assault by bodily force

209

595

3.66

62.46

2.7

3.3

34.31

36.01

umol/l

0.35

195

565

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

106

177

6.71

62.26

2.8

2.6

36.83

34.76

umol/l

0.35

161

Follow-up examination after treatment for conditions other than malignant neoplasms

708

2342

2.04

62.11

2.7

2.2

32.51

34.70

umol/l

1.60

642

2094

Cytomegaloviral disease, including avohilmo

112

198

6.29

61.98

5.7

3.1

31.36

33.66

umol/l

0.43

104

179

Viral infections of the central nervous system

197

545

3.79

61.59

2.2

3.0

28.79

34.83

umol/l

3.01

171

493

Abnormal findings on diagnostic imaging of lung

964

5158

1.80

61.55

2.3

2.6

31.30

33.72

umol/l

2.58

866

4597

Encephalitis

122

235

5.67

61.31

3.0

3.7

28.33

34.09

umol/l

2.28

107

216

Disorders of lens

1272

4720

1.69

61.02

3.2

2.8

34.29

34.18

umol/l

0.05

1168

4272

Toxic effect of other and unspecified substances

10.76

60.86

2.3

4.4

32.79

36.63

umol/l

0.63

Dorsalgia

1697

5733

1.58

60.69

2.8

2.7

32.59

34.06

umol/l

1.56

1528

5207

AV-block

370

1236

2.62

60.65

2.2

2.3

31.89

34.48

umol/l

1.09

329

1082

Hyperlipidaemia, other/unspecified

717

3320

1.97

60.62

2.3

2.5

30.26

34.12

umol/l

4.68

624

2966

Urinary track infection

783

1985

2.00

60.59

2.8

2.6

31.46

33.52

umol/l

1.47

712

1812

Other/unspecified cytomegaloviral diseases

100

163

6.92

60.28

5.8

3.2

31.72

34.16

umol/l

0.41

147

Mental and behavioural disorders due to cannabinoids

100

161

6.63

60.16

2.5

3.9

37.05

35.86

umol/l

0.15

154

Injury, poisoning and certain other consequences of external causes

795

2035

1.98

60.05

3.0

2.5

34.96

33.79

umol/l

0.37

725

1857

Other diseases of intestine

366

1463

2.58

59.61

4.1

2.5

35.19

33.34

umol/l

0.79

341

1322

Mental retardation, excluding more controls

111

191

5.94

59.31

2.3

3.6

34.30

34.07

umol/l

0.03

104

180

Other acute viral hepatitis

9.30

59.24

3.6

4.6

38.87

36.93

umol/l

0.21

Intracerebral haemorrhage

297

1077

2.85

58.77

3.0

2.6

32.72

34.85

umol/l

0.71

269

951

Calcific aortic valvular stenosis, operated

621

2981

2.05

58.60

2.7

2.2

34.46

32.53

umol/l

1.03

556

2584

Calcific aortic valvular stenosis

621

2981

2.05

58.60

2.7

2.2

34.46

32.53

umol/l

1.03

556

2584

Osteomyelitis

202

589

3.62

58.59

3.1

2.9

29.62

36.16

umol/l

2.30

181

538

Other encephalitis

117

227

5.64

58.39

3.0

3.6

28.10

33.81

umol/l

2.25

102

209

Calcific aortic valvular stenosis, diagnosis (helper)

618

2973

2.04

57.96

2.7

2.2

34.43

32.49

umol/l

1.04

553

2577

Operations 2 for CAVS

618

2973

2.04

57.96

2.7

2.2

34.43

32.49

umol/l

1.04

553

2577

Secondary uncertain malignant neoplasm

306

1138

2.77

57.71

1.9

2.5

36.02

33.49

umol/l

0.79

278

1013

Calcific aortic valvular stenosis, including rheumatic fever

619

2982

2.04

57.64

2.7

2.2

34.44

32.48

umol/l

1.06

554

2585

Other diseases of stomach and duodenum

177

478

3.88

57.36

5.2

2.3

41.93

35.74

umol/l

1.31

165

427

Injuries to the knee and lower leg

2033

7394

1.50

57.17

2.9

2.6

34.78

33.12

umol/l

1.62

1840

6668

Obesity, other/unspecified

586

2897

2.06

56.78

3.7

2.8

35.95

33.70

umol/l

1.15

532

2651

Fall on and from stairs and steps

535

2567

2.13

56.46

3.3

2.8

33.99

33.81

umol/l

0.05

487

2330

Toxic effects of substances chiefly nonmedicinal as to source

278

997

2.89

56.31

2.7

3.0

31.98

35.41

umol/l

1.49

260

915

Other and unspecified effects of external causes

521

2476

2.14

56.25

2.5

2.9

32.66

34.34

umol/l

0.98

480

2268

Type 1 diabetes, wide definition

414

1790

2.36

56.25

2.2

2.5

28.62

33.64

umol/l

4.68

370

1615

Other complications of surgical and medical care, not elsewhere classified

235

768

3.17

56.22

3.2

2.8

32.62

35.17

umol/l

0.75

213

696

Other/unspecified dorsalgia

682

3522

1.94

56.05

2.9

2.7

33.13

34.17

umol/l

0.50

623

3196

Alzheimer disease, excluding more controls

307

707

2.87

55.88

1.4

2.0

25.86

35.74

umol/l

9.76

258

642

Viral infections of the central nervous system, including avohilmo

201

601

3.49

55.80

2.2

3.0

28.92

34.68

umol/l

2.92

174

545

Misadventures to patients during surgical and medical care

320

1238

2.66

55.79

2.7

2.6

33.65

34.15

umol/l

0.12

301

1114

Hernia of abdominal wall

904

5174

1.78

55.78

3.9

2.6

36.95

33.54

umol/l

3.53

822

4676

Disorders of psychological development

260

828

2.99

55.77

2.9

3.0

33.76

33.02

umol/l

0.16

239

768

Sub-endpoint used in defining T1D endpoints

573

2782

2.06

55.75

2.3

2.8

30.45

34.21

umol/l

3.63

517

2508

Vascular diseases of the intestine

132

294

4.79

55.63

3.8

2.9

35.70

33.41

umol/l

0.35

116

257

809

4448

1.83

55.38

2.6

2.9

32.51

34.03

umol/l

1.03

738

4030

Alcohol induced polyneuropathy

100

9.10

55.09

4.1

3.6

33.17

35.38

umol/l

0.32

Diabetic maculopathy, excluding more controls

244

824

3.06

55.07

2.0

2.2

28.52

33.03

umol/l

1.98

217

730

Nerve, nerve root and plexus disorders

1837

7371

1.51

54.68

2.7

33.16

33.78

umol/l

0.43

1641

6659

Psychotic depression

127

276

4.77

54.61

3.0

29.72

34.46

umol/l

1.45

116

260

Sequelae of injuries of head

166

445

3.95

54.59

2.9

3.3

33.87

36.16

umol/l

0.38

154

407

Abnormalities of heart beat

616

3041

1.99

54.57

2.4

31.21

33.81

umol/l

2.07

558

2706

Lower back pain or/and sciatica

1839

7661

1.50

54.25

2.9

2.7

32.96

33.74

umol/l

0.65

1662

6911

Secondary parkinsonism, excluding more controls

8.20

54.11

2.0

2.7

29.81

34.93

umol/l

0.90

Post-traumatic stress disorder

155

396

4.02

53.87

2.2

3.0

29.38

32.98

umol/l

1.81

142

375

Dilated cardiomyopathy

317

1248

2.64

53.75

2.5

2.7

30.57

34.72

umol/l

2.12

288

1113

Acute posthaemorrhagic anaemia

120

255

5.03

53.60

5.3

2.4

38.05

32.43

umol/l

1.47

108

220

Injuries to the shoulder and upper arm

1536

7739

1.55

53.33

2.8

2.7

32.96

33.83

umol/l

0.74

1377

6980

COPD, hospital admissions 1, only main diagnosis

704

3250

1.90

52.36

2.1

2.3

31.50

33.15

umol/l

1.14

627

2864

Extrapyramidal and movement disorders

740

4076

1.85

52.04

2.2

2.5

29.88

33.66

umol/l

4.09

657

3637

Other noninfective gastroenteritis and colitis

488

2341

2.13

51.43

3.0

2.8

32.48

33.96

umol/l

0.71

454

2125

Other pleural conditions

261

953

2.84

51.26

3.4

2.5

32.05

34.47

umol/l

0.80

237

841

Leisure time condition

386

1696

2.33

50.92

3.5

2.7

32.93

33.73

umol/l

0.25

349

1539

Amputation of toe

209

679

3.23

50.92

2.3

2.7

31.83

35.40

umol/l

0.91

174

603

Myocardial infarction, strict

874

3539

1.78

50.88

2.3

2.7

31.05

34.40

umol/l

3.76

779

3156

Cerebral palsy and other paralytic syndromes

266

985

2.79

50.74

3.0

2.8

32.89

34.87

umol/l

0.63

249

893

Intentional self-harm by sharp object

149

6.33

50.46

2.3

3.6

31.12

35.19

umol/l

1.03

139

Diabetic nephropathy

457

2144

2.19

50.21

2.5

3.1

30.22

35.06

umol/l

4.27

411

1937

Exclusions for E4_PCOS_BROAD

377

1653

2.34

49.92

2.9

3.0

31.92

34.86

umol/l

1.66

340

1517

Abnormal results of function studies

224

766

3.04

49.65

3.4

3.1

34.90

36.71

umol/l

0.38

207

696

Dermatitis

1114

6781

1.62

49.60

2.9

2.7

32.28

34.07

umol/l

2.10

1009

6119

Periodontitis

1700

7305

1.50

49.07

2.9

2.7

34.46

33.49

umol/l

0.63

1542

6592

Hyperosmolality and hypernatraemia

100

7.99

49.00

2.1

3.2

28.53

39.38

umol/l

1.99

Dementia

786

3009

1.81

48.86

1.9

2.2

26.47

33.77

umol/l

15.69

655

2656

Hernia

1579

6988

1.51

48.75

3.2

2.6

34.31

33.79

umol/l

0.36

1420

6317

Speech and linguistic disorders

214

686

3.09

48.72

3.2

3.1

34.28

32.89

umol/l

0.28

198

633

Mental and behavioural disorders due to tobacco

224

776

3.00

48.59

2.2

3.1

29.94

34.64

umol/l

2.77

194

713

Chronic periodontitis, including avohilmo

1695

7311

1.49

48.32

2.9

2.7

34.44

33.49

umol/l

0.61

1538

6595

Hypercalcemia

143

378

4.03

48.20

2.9

3.0

32.78

34.45

umol/l

0.32

123

336

Hypocalcemia

182

5.71

48.15

4.0

3.1

34.76

34.20

umol/l

0.07

167

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

344

1265

2.41

48.13

2.7

3.1

32.72

33.33

umol/l

0.20

318

1182

ILD, hospital admission 2, with pulmonary infections

214

725

3.05

48.10

2.5

31.19

33.88

umol/l

1.09

203

637

Anaemia in chronic diseases classified elsewhere

197

5.49

48.08

3.7

2.6

31.34

32.79

umol/l

0.28

174

Myocardial infarction, without ST-elevation

804

4175

1.77

48.00

2.1

2.4

30.18

33.34

umol/l

3.21

702

3699

Cystitis

1362

5221

1.56

47.84

2.9

2.5

32.02

33.75

umol/l

1.67

1227

4713

Charcot foot

115

7.18

47.70

3.3

2.8

32.86

35.43

umol/l

0.33

105

Acute upper respiratory infections of multiple and unspecified sites

1284

6022

1.57

47.40

3.1

2.7

33.81

33.63

umol/l

0.07

1161

5449

Other disorders of adrenal gland

137

355

4.08

47.33

2.6

3.2

30.72

33.50

umol/l

0.74

122

324

Candidiasis, including avohilmo

524

2660

2.00

47.29

3.7

2.6

35.52

33.02

umol/l

1.43

477

2413

Adrenocortical insufficiency

116

267

4.63

47.00

2.6

3.1

29.02

33.05

umol/l

1.18

103

242

Nonischemic cardiomyopathy

243

894

2.81

46.96

2.8

2.9

32.81

35.30

umol/l

0.72

227

800

Smoking dependency

224

792

2.94

46.83

2.2

3.1

29.94

35.41

umol/l

2.59

194

728

Extreme obesity with alveolar hypoventilation

131

332

4.20

46.79

2.9

3.1

34.64

33.73

umol/l

0.20

121

301

Diabetic retinopathy, excluding more controls

570

1609

2.03

46.73

2.7

2.9

31.11

35.18

umol/l

3.93

510

1451

Unspecified dementia

235

753

2.87

46.68

2.2

2.1

26.95

33.92

umol/l

4.95

195

644

Other problems related to primary support group, including family circumstances

235

826

2.85

46.57

3.9

2.9

33.39

33.17

umol/l

0.06

221

775

Schizoaffective disorder

175

540

3.36

46.19

1.7

3.3

30.48

36.85

umol/l

2.31

153

508

Other arrhythmias

936

4190

1.68

46.15

2.4

2.8

31.72

34.72

umol/l

3.48

842

3801

Secondary right heart disease

130

331

4.17

46.10

2.9

2.5

35.07

33.30

umol/l

0.24

121

286

Any dementia

743

2883

1.81

46.05

1.8

2.2

26.62

33.42

umol/l

12.36

610

2517

Other pulmonary heart/vessel disease

140

376

3.94

46.03

2.8

2.6

35.15

33.90

umol/l

0.17

131

327

Diseases of spleen

154

6.14

45.96

4.9

3.0

39.78

34.04

umol/l

1.19

140

Exposure to other specified factors

1381

7845

1.52

45.95

2.8

33.56

33.74

umol/l

0.09

1224

7151

Sequelae with surgical and medical care as external cause

416

1966

2.17

45.92

2.4

2.6

32.81

33.64

umol/l

0.29

376

1770

Liquid cancers

544

2672

1.96

45.67

2.6

35.07

32.78

umol/l

1.10

490

2386

Event of undetermined intent

174

542

3.35

45.38

2.7

3.2

33.91

34.34

umol/l

0.09

159

501

Open wound of lower leg

318

1352

2.41

45.33

3.1

2.9

35.32

33.82

umol/l

0.55

283

1225

Parkinson's disease, excluding more controls

222

721

2.89

45.17

1.6

2.2

29.01

36.27

umol/l

2.56

186

650

Artificial opening status

156

456

3.60

45.14

3.7

2.5

33.35

35.66

umol/l

0.61

142

409

Congenital malformations of gallbladder, bile ducts and liver

8.63

45.13

9.5

3.3

33.60

34.47

umol/l

0.10

Other diseases of anus and rectum

552

2892

1.93

44.89

2.9

2.3

34.90

32.79

umol/l

0.56

494

2576

Other infectious diseases, including avohilmo

220

788

2.89

44.85

2.9

2.7

34.75

35.38

umol/l

0.11

191

709

Maltreatment syndromes

134

354

3.95

44.85

2.6

3.4

34.13

33.91

umol/l

0.04

127

332

Diaphragmatic hernia

658

3662

1.83

44.82

3.0

2.4

31.10

33.24

umol/l

1.70

583

3279

Diverticular disease of intestine

1212

4833

1.58

44.31

3.3

2.5

33.92

33.76

umol/l

0.07

1081

4334

Senile cataract

1126

4315

1.61

44.02

3.1

2.7

33.55

33.95

umol/l

0.18

1033

3889

Unspecified haematuria

825

3975

1.71

43.78

3.2

2.6

34.41

33.53

umol/l

0.42

743

3568

Diffuse brain injury

183

5.20

43.12

4.5

3.1

37.50

42.07

umol/l

0.41

166

All influenza (not pneumonia)

280

1150

2.49

43.02

2.9

3.0

31.79

35.27

umol/l

1.92

257

1039

Adenocarcinoma and ductal carcinoma of pancreas

111

267

4.41

42.49

1.8

2.6

35.46

38.49

umol/l

0.32

102

242

Sleep disorders (combined)

1795

6524

1.45

42.43

2.6

2.7

32.57

33.93

umol/l

1.43

1628

5860

Other blood glucose lowering drugs, excl. Insulins

312

1357

2.36

42.29

3.7

2.3

37.47

32.06

umol/l

2.51

291

1192

Obesity related asthma

631

3540

1.81

41.87

2.7

2.9

32.29

34.48

umol/l

1.69

579

3220

Asthma (diagnoses ohter than nonallergic)

1459

8035

1.48

41.55

2.7

31.98

33.83

umol/l

2.44

1326

7241

Abnormalities of gait and mobility

280

1173

2.46

41.52

3.2

2.6

33.05

34.69

umol/l

0.45

252

1044

Other extrapyramidal and movement disorders in other diseases

467

2401

1.98

40.88

2.3

2.7

30.02

33.85

umol/l

3.78

425

2153

Parkinson's disease, strict definition, excluding more controls

202

669

2.88

40.87

1.6

2.1

28.44

36.38

umol/l

2.69

169

603

Other local infections of skin and subcutaneous tissue

235

914

2.65

40.77

2.9

31.86

35.86

umol/l

1.29

209

829

Other dorsopathies, not elsewhere classified

1610

5743

1.47

40.73

2.8

2.7

32.54

34.05

umol/l

1.67

1432

5217

Idiopathic gout

244

971

2.61

40.59

2.4

30.82

34.62

umol/l

1.58

222

853

Other and unspecified local infections of skin and subcutaneous tissue

223

848

2.72

40.50

3.0

2.9

31.24

36.17

umol/l

1.98

199

770

Noninfectious colitis NAS

280

1184

2.43

40.49

2.9

33.04

34.98

umol/l

0.61

264

1083

Other embolism and thrombosis

253

1022

2.54

40.44

4.1

2.2

34.10

33.09

umol/l

0.27

230

906

Dementia, including avohilmo

844

3472

1.68

40.40

1.9

2.3

26.94

33.37

umol/l

13.52

704

3062

Dermatitis and eczema

1863

7838

1.42

40.24

2.7

31.92

33.98

umol/l

3.75

1682

7076

Other and unspecified dermatitis

895

5569

1.63

40.22

2.9

2.7

32.24

34.12

umol/l

1.89

815

5016

Other infectious diseases

187

652

2.98

40.17

3.0

2.7

35.75

35.82

umol/l

0.01

162

584

Sequelae of injuries, of poisoning and of other consequences of external causes

453

2321

1.99

40.06

3.1

3.0

33.88

34.84

umol/l

0.35

417

2122

Suppurative and necrotic conditions of lower respiratory tract

165

539

3.22

39.99

3.2

2.9

38.42

35.57

umol/l

0.22

151

484

Evidence of alcohol involvement determined by blood alcohol level

111

6.68

39.66

2.7

4.1

35.27

35.48

umol/l

0.02

102

Glucagon-like peptide-1 (GLP-1) analogues

547

2990

1.86

39.60

3.4

2.7

35.58

33.35

umol/l

1.21

503

2729

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

547

2990

1.86

39.60

3.4

2.7

35.58

33.35

umol/l

1.21

503

2729

Other viral diseases

515

2752

1.89

39.53

3.9

3.0

32.81

34.29

umol/l

0.82

473

2533

ILD, hospital admissions 3, with pneumonia sepsis

186

652

2.95

39.46

2.6

31.49

34.92

umol/l

1.37

177

569

Intestinal malabsorption

127

355

3.76

39.34

3.9

2.5

32.70

32.09

umol/l

0.11

116

318

Unspecified privation

236

937

2.60

39.26

2.6

2.9

34.09

35.18

umol/l

0.24

214

853

Hydronephrosis

216

821

2.70

39.12

2.0

2.4

30.51

34.63

umol/l

1.58

192

735

Other disorders starting during childhood or adolecense, excluding more controls

161

5.12

39.04

3.8

3.5

33.10

32.81

umol/l

0.05

153

Personal history of certain other diseases

7.73

39.00

2.9

2.3

31.57

34.80

umol/l

0.44

Aneurysms, operations, SAH

301

1335

2.31

38.95

2.4

2.8

33.07

34.90

umol/l

0.53

270

1206

Spondylopathies

1317

5215

1.51

38.94

2.5

2.7

33.12

34.30

umol/l

0.79

1163

4720

Congenital malformations, deformations and chromosomal abnormalities

909

5421

1.60

38.61

3.1

2.9

32.94

33.95

umol/l

0.66

830

4943

Undefined dementia

236

863

2.58

38.55

2.2

2.0

26.90

32.38

umol/l

3.57

196

730

Neuromuscular dysfunction of bladder

210

795

2.73

38.54

2.5

2.9

30.10

34.97

umol/l

2.02

193

722

Other respiratory diseases principally affecting the interstitium

370

1791

2.12

38.50

2.6

2.4

32.69

33.45

umol/l

0.25

352

1578

Other diseases of oesophagus

203

755

2.77

38.48

3.5

2.2

35.15

33.54

umol/l

0.28

184

671

Combinations of oral blood glucose lowering drugs

531

2912

1.86

38.16

3.1

2.5

35.35

32.74

umol/l

1.49

487

2619

Abnormal findings on diagnostic imaging of other body structures

287

1260

2.33

38.13

3.4

2.8

32.04

34.64

umol/l

1.16

255

1128

Degenerative diseases of the nervous system

672

2800

1.75

37.77

2.3

2.1

28.37

32.99

umol/l

5.52

567

2416

Exclusions for E4_PCOS_CONSORTIUM

1008

4012

1.58

37.60

2.7

2.8

32.87

33.69

umol/l

0.32

908

3647

Thiazolidinediones

242

993

2.51

37.59

3.8

2.3

35.48

32.56

umol/l

0.93

225

880

Visual disturbances and blindness

890

5623

1.60

37.44

2.4

2.7

30.97

33.55

umol/l

3.43

802

5046

Ulcer of oesophagus

167

570

3.05

37.34

2.8

2.3

32.85

34.80

umol/l

0.34

153

504

Superficial injury of abdomen, lower back and pelvis

300

1354

2.26

37.22

2.8

32.97

33.97

umol/l

0.35

274

1243

Oesophagitis

138

422

3.41

37.18

3.1

2.3

35.16

36.38

umol/l

0.16

120

380

Paralytic ileus

110

290

4.00

37.16

2.7

2.5

31.64

34.15

umol/l

0.56

102

258

Mental disorders, not otherwise specified

161

539

3.08

37.03

2.8

3.3

33.34

34.75

umol/l

0.27

140

505

Sleep apnoea

1577

6982

1.43

36.94

2.8

2.7

33.03

33.96

umol/l

0.79

1451

6286

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

177

627

2.92

36.93

2.7

31.92

35.42

umol/l

0.85

159

561

Viral and other specified intestinal infections, including avohilmo

432

2148

1.96

36.82

3.2

2.7

32.73

34.24

umol/l

0.57

402

1975

Disorders resulting from impaired renal tubular function

120

340

3.76

36.72

2.2

2.9

26.87

32.71

umol/l

3.22

110

304

Somatoform disorder

272

1189

2.33

36.37

2.4

3.0

32.20

34.75

umol/l

0.76

245

1087

Intestinal adhesions without obstruction

188

693

2.80

36.33

2.7

2.4

34.86

33.04

umol/l

0.29

164

622

Viral and other specified intestinal infections

338

1571

2.13

36.27

3.3

2.6

31.05

34.43

umol/l

1.75

315

1442

Other condition

295

1339

2.26

36.21

2.9

33.55

34.70

umol/l

0.34

284

1222

Tubulo-interstitial nephritis, not specified as acute or chronic

131

395

3.42

35.88

2.2

2.4

31.77

33.89

umol/l

0.43

111

350

Malnutrition

184

4.89

35.53

2.7

3.1

33.58

35.15

umol/l

0.19

163

Arthropathies in other diseases classified elsewhere

107

286

3.95

35.51

3.0

2.9

32.90

33.70

umol/l

0.12

255

Ventral hernia

444

2357

1.92

35.39

3.5

2.6

36.44

33.99

umol/l

1.14

403

2131

Benign neoplasm: Colon, unspecified

489

2680

1.86

35.32

3.6

2.5

34.09

33.32

umol/l

0.29

442

2385

Diabetic neuropathy

320

1516

2.18

35.30

2.9

3.2

33.61

34.88

umol/l

0.35

289

1373

Superficial injury of thorax

302

1398

2.21

35.28

3.5

2.9

33.52

34.11

umol/l

0.16

276

1268

Dissociative [conversion] disorders

179

4.76

35.27

2.6

2.9

31.96

32.50

umol/l

0.08

164

Other symptoms and signs involving the digestive system and abdomen

250

1070

2.38

35.04

3.0

2.0

34.17

31.48

umol/l

0.90

229

960

Somnolence

7.03

34.88

3.1

4.4

39.57

36.76

umol/l

0.16

Hypothyroidism, strict autoimmune

1080

4686

1.52

34.64

2.8

2.5

33.84

34.00

umol/l

0.06

988

4198

Postprocedural disorders of digestive system, not elsewhere classified

100

260

4.08

34.54

4.0

2.7

32.34

32.61

umol/l

0.05

233

Myocarditis

211

4.35

34.40

2.4

2.1

33.19

36.52

umol/l

0.31

187

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

217

883

2.54

34.38

3.3

2.7

34.25

34.92

umol/l

0.11

194

797

Hypothermia

175

4.94

33.99

2.1

3.5

31.07

35.01

umol/l

0.70

159

Other diseases of arteries and capillaries

190

730

2.68

33.87

2.7

2.8

32.76

35.03

umol/l

0.45

167

657

Other headache syndromes

595

3473

1.72

33.85

2.6

2.9

31.87

34.92

umol/l

2.19

540

3146

Injuries to the elbow and forearm

1146

6669

1.48

33.83

2.5

2.8

32.23

33.95

umol/l

1.34

1019

6042

Abnormal serum enzyme levels

638

3683

1.70

33.76

2.8

2.7

31.82

33.80

umol/l

1.52

587

3296

Amputation of ankle bones

192

4.67

33.71

4.1

3.2

30.73

35.55

umol/l

0.89

169

Specific development disorders of speech and language

143

454

3.15

33.70

3.1

3.2

32.17

33.85

umol/l

0.32

135

418

Finngen Rheumatological endpoints

1501

6011

1.43

33.61

2.9

2.8

33.65

34.09

umol/l

0.21

1365

5448

Disorders of parathyroid gland

346

1695

2.05

33.59

2.3

2.6

30.25

33.14

umol/l

1.48

305

1522

Functional dyspepsia

399

2078

1.95

33.56

3.1

2.3

30.91

32.81

umol/l

0.83

355

1851

Other viral diseases, including avohilmo

606

3545

1.71

33.44

3.5

3.0

32.62

34.17

umol/l

1.02

561

3259

Toxic effect of ethanol

112

322

3.65

33.36

2.7

3.6

31.81

35.27

umol/l

0.90

104

295

Pain in joint

878

3426

1.59

33.31

3.0

2.5

33.18

33.98

umol/l

0.46

787

3110

Enlarged lymph nodes

226

948

2.42

33.17

3.2

2.3

34.08

33.39

umol/l

0.17

213

859

Other disorders of kidney and ureter

279

1288

2.23

33.01

2.3

2.7

31.07

33.98

umol/l

1.13

252

1160

Inflammatory bowel disease

535

3074

1.76

32.82

3.4

2.9

31.64

34.39

umol/l

2.56

496

2801

Disorders of choroid and retina

1370

6738

1.43

32.77

2.5

2.7

31.44

34.02

umol/l

3.99

1202

6070

Colectomy operation

332

1644

2.07

32.59

3.0

2.6

32.40

33.99

umol/l

0.50

309

1467

Lung cancer and mesothelioma

311

1258

2.13

32.54

1.8

2.4

32.58

34.61

umol/l

0.83

270

1112

Acute gastritis

153

538

2.93

32.35

3.4

2.3

33.47

35.71

umol/l

0.35

145

482

Injuries to the ankle and foot

1154

6765

1.47

32.22

2.7

2.9

33.77

33.96

umol/l

0.09

1054

6169

Systemic connective tissue disorders

552

3218

1.74

32.14

2.4

2.6

29.87

33.50

umol/l

3.47

487

2871

Agranulocytosis

229

985

2.39

32.08

3.6

2.8

35.87

34.91

umol/l

0.17

206

896

Other retinal disorders

1105

5710

1.48

31.87

2.4

2.6

31.37

33.71

umol/l

2.78

951

5119

Wide developmental disorders, excluding more controls

123

5.34

31.82

2.1

3.6

32.77

33.31

umol/l

0.08

117

Ulcerative colitis, NAS

265

1216

2.23

31.71

3.8

3.0

30.21

35.24

umol/l

3.43

246

1117

Arterial embolism and thrombosis

132

433

3.16

31.61

1.9

2.6

34.68

33.46

umol/l

0.18

122

385

Epidural haemorrhage

10.11

31.41

1.7

3.5

37.16

36.74

umol/l

0.02

Persistent delusional disorders

162

599

2.79

31.23

2.0

3.0

30.94

36.31

umol/l

1.68

143

539

Complications of internal orthopaedic prosthetic devices, implants and grafts

385

2035

1.92

31.15

2.1

2.4

30.04

33.14

umol/l

1.77

330

1798

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

976

5955

1.50

31.15

3.0

2.9

33.00

33.97

umol/l

0.63

890

5432

Hypertensive Renal Disease

218

4.11

30.60

1.7

2.0

26.40

32.23

umol/l

1.53

178

Familial hypercholesterolemia

263

1221

2.20

30.55

3.0

2.3

32.42

34.17

umol/l

0.62

235

1078

Unspecified acute lower respiratory infection

305

1500

2.08

30.49

3.1

2.9

32.80

34.79

umol/l

0.59

285

1359

Generalized epilepsy

104

303

3.58

30.31

2.7

3.7

34.13

33.36

umol/l

0.15

282

Social phobias

136

465

2.98

30.08

2.3

3.2

32.08

36.40

umol/l

1.04

123

438

Angina pectoris

922

4040

1.53

30.05

2.5

2.7

30.92

34.72

umol/l

5.27

823

3612

Symptoms and signs involving speech and voice

542

3206

1.71

30.00

2.4

2.6

32.29

33.60

umol/l

0.57

485

2875

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

285

1376

2.12

29.96

1.9

2.6

32.68

33.33

umol/l

0.18

260

1240

Obsessive-compulsive disorder

113

348

3.32

29.89

2.3

3.0

33.54

34.05

umol/l

0.09

103

328

Disorder of lipoprotein metabolism, unspecified

235

1053

2.28

29.84

3.0

2.4

33.42

34.09

umol/l

0.17

202

932

Visual disturbances

794

5180

1.55

29.30

2.5

2.7

30.77

33.56

umol/l

3.57

714

4653

Cardiodefibrillation

660

4124

1.62

29.22

2.6

2.5

31.53

33.34

umol/l

1.41

587

3681

Umbilical hernia

519

3061

1.72

29.17

4.5

2.8

37.51

34.43

umol/l

1.85

471

2793

Amiodarone users

228

1023

2.30

29.11

2.7

2.6

33.03

34.65

umol/l

0.46

204

902

Other diseases of pericardium

106

324

3.40

28.66

2.9

2.8

35.43

36.80

umol/l

0.14

295

Emotional disorders and disorders of social functioning with onset specific to childhood

102

296

3.48

28.64

2.3

2.9

32.14

31.53

umol/l

0.14

280

Spinal stenosis

874

4268

1.52

28.63

2.3

2.6

32.60

34.06

umol/l

0.80

761

3843

Other cataract

754

3600

1.57

28.50

2.7

2.6

34.52

33.88

umol/l

0.22

676

3234

Diseases of pulp and periapical tissues, including avohilmo

1592

6025

1.37

28.35

2.7

2.6

33.37

33.24

umol/l

0.07

1431

5429

Superficial injury of hip and thigh

279

1364

2.08

28.31

2.6

33.98

33.67

umol/l

0.06

251

1227

Viral pneumonia (known virus, not influenza)

246

3.84

28.30

2.9

3.7

29.49

36.55

umol/l

2.49

221

Use of biperiden

130

453

2.99

28.19

1.7

3.1

30.79

35.78

umol/l

1.23

117

414

Amputation of thigh

242

3.83

28.10

2.3

2.4

31.75

33.17

umol/l

0.17

208

Amputation of foot

248

3.84

28.07

2.4

2.7

31.34

32.80

umol/l

0.20

217

Injuries to the neck

387

2119

1.85

28.06

2.4

2.9

32.51

34.02

umol/l

0.48

348

1938

Other general symptoms and signs

271

3.57

27.96

2.3

2.9

31.20

33.01

umol/l

0.37

248

Benign neoplasm of other and ill-defined parts of digestive system

323

1674

1.97

27.89

3.4

2.6

35.86

33.59

umol/l

0.77

293

1497

Malignant neoplasm, without specification of site, including Hilmo

107

334

3.32

27.88

2.0

2.5

37.98

33.67

umol/l

0.85

297

Acute upper respiratory infections

1618

7167

1.36

27.84

2.9

2.6

33.62

33.42

umol/l

0.09

1468

6430

Fracture of foot, except ankle

409

2283

1.82

27.82

3.0

2.9

34.50

34.59

umol/l

0.02

367

2088

Disorders of speech understanding and production

119

389

3.14

27.82

3.0

3.2

32.10

33.49

umol/l

0.22

113

354

Budesonide

249

1175

2.16

27.78

3.5

2.8

30.75

35.49

umol/l

2.63

231

1066

Alzheimer’s disease (Late onset), excluding more controls

213

587

2.39

27.76

1.4

1.9

22.97

35.21

umol/l

15.93

175

527

Transient ischemic attack

846

4478

1.52

27.70

2.2

2.6

30.13

34.11

umol/l

5.18

743

3999

Colorectal cancer, including Hilmo

452

2418

1.77

27.66

2.2

2.5

34.22

32.71

umol/l

0.49

414

2149

Unknown and unspecified causes of morbidity

115

376

3.13

27.62

2.8

2.3

33.66

33.13

umol/l

0.09

107

341

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

315

1573

1.98

27.55

3.2

3.1

31.74

34.74

umol/l

1.59

295

1447

Agoraphobia

157

4.49

27.35

2.5

3.2

31.98

32.65

umol/l

0.10

147

Vascular dementia

184

742

2.45

27.24

1.6

2.0

26.30

33.11

umol/l

3.22

146

632

Weight loss

210

935

2.31

27.24

2.4

2.8

30.95

34.44

umol/l

1.37

183

842

Discitis, unspecified

143

4.84

27.22

2.7

2.9

30.00

34.83

umol/l

1.39

132

Injury of other and unspecified intrathoracic organs

152

586

2.69

27.14

2.8

2.9

33.88

36.96

umol/l

0.70

141

523

Hyperparathyroidism

295

1477

2.01

27.13

2.2

2.5

30.00

32.95

umol/l

1.32

259

1320

Injury of intra-abdominal organs

198

4.12

27.11

3.0

3.2

45.01

33.37

umol/l

0.52

182

Subarachnoid haemorrhage

192

825

2.38

27.00

2.3

2.8

33.03

35.58

umol/l

0.52

172

748

Behavioural syndromes associated with physiological disturbances and physical factors

1456

7224

1.37

26.95

2.6

2.8

32.31

34.05

umol/l

2.00

1308

6555

Visual impairment including blindness (binocular or monocular)

147

559

2.71

26.89

1.9

2.8

31.89

34.50

umol/l

0.73

132

493

Fall involving bed

284

3.52

26.78

2.6

32.66

34.07

umol/l

0.18

245

Colorectal cancer

404

2180

1.80

26.65

2.1

2.5

32.37

32.87

umol/l

0.16

369

1930

Eating disorder

126

443

2.89

26.46

2.7

2.8

29.43

31.44

umol/l

0.40

110

418

Secondary malignant neoplasm of respiratory and digestive organs

134

4.90

26.44

1.4

2.4

37.62

32.72

umol/l

0.58

120

Other eating disorders

251

3.60

26.32

3.1

2.9

29.70

32.44

umol/l

0.42

232

Complications of cardiac and vascular prosthetic devices, implants and grafts

172

4.36

26.31

2.5

29.28

32.59

umol/l

0.59

150

Ulcerative colitis

409

2323

1.79

26.29

3.6

2.9

31.35

34.50

umol/l

2.47

375

2121

Attention to artificial openings

100

312

3.34

26.23

2.5

2.7

31.76

35.63

umol/l

0.82

280

Other viral diseases, not elsewhere classified

328

1737

1.91

26.22

3.5

3.0

32.63

34.73

umol/l

1.01

298

1594

Dorsopathies

1551

5799

1.36

26.06

2.7

32.36

34.01

umol/l

1.74

1379

5271

Lesion of ulnar nerve

267

1327

2.05

26.05

2.2

2.9

33.69

35.26

umol/l

0.48

248

1216

Other sleep disorders

206

927

2.27

25.96

2.7

2.8

31.19

34.44

umol/l

1.11

188

843

Adenocarcinoma of pancreas

204

3.97

25.94

1.5

2.4

33.11

32.23

umol/l

0.12

184

Left ventricular outflow tract obstruction (LVOTO), broad definition

224

1046

2.20

25.94

3.3

38.41

35.98

umol/l

0.58

209

972

Tobacco use

128

463

2.87

25.91

2.6

3.1

31.66

36.58

umol/l

1.16

120

423

Other congenital malformations of the digestive system

122

428

2.96

25.84

6.8

3.2

36.89

32.72

umol/l

0.87

111

395

Other intervertebral disc disorders

1268

5441

1.40

25.79

2.6

2.7

32.94

34.19

umol/l

0.89

1150

4938

Autism spe, excluding more controls

6.42

25.78

1.6

3.9

31.36

36.01

umol/l

0.84

Cholecystectomy

1086

6538

1.42

25.60

2.6

32.35

33.50

umol/l

0.95

1005

5846

Diseases of the eye and adnexa

1206

4297

1.41

25.41

3.1

2.9

34.21

34.60

umol/l

0.19

1115

3909

Superficial injury of lower leg

406

2324

1.77

25.37

3.2

2.6

34.85

33.01

umol/l

0.34

366

2111

Crohn disease

234

1119

2.13

25.32

3.8

3.1

31.94

35.84

umol/l

1.98

219

1028

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

323

1677

1.91

25.29

3.2

3.1

32.31

34.61

umol/l

0.92

303

1542

Drug-induced hypoglycaemia without coma

115

5.13

25.26

3.0

3.9

30.35

35.61

umol/l

0.76

102

Osteonecrosis

141

544

2.68

25.17

2.2

2.8

32.87

35.62

umol/l

0.54

127

500

Soft tissue disorders

1573

6002

1.35

25.02

2.9

2.6

33.20

34.10

umol/l

0.54

1415

5421

Fall on same level involving ice and snow

913

6336

1.45

24.77

3.0

2.7

33.75

33.81

umol/l

0.02

827

5696

Malignant neoplasm, without specification of site

239

3.62

24.72

2.1

2.4

37.52

35.43

umol/l

0.25

211

Pruritus

196

882

2.27

24.71

2.9

2.7

30.04

35.16

umol/l

2.17

176

801

Status post-ami

459

2061

1.71

24.39

2.1

2.4

29.40

33.87

umol/l

3.86

396

1819

Other symptoms and signs involving the circulatory and respiratory systems

132

500

2.71

24.33

2.9

2.8

29.92

34.17

umol/l

1.18

119

449

Sleep apnoea, including avohilmo

1563

7100

1.34

24.30

2.8

2.7

33.37

33.78

umol/l

0.21

1441

6392

Injuries to unspecified part of trunk, limb or body region

201

924

2.23

24.15

2.4

2.9

30.81

35.39

umol/l

1.85

186

835

Unspecified event, undetermined intent

192

3.95

24.10

2.7

3.7

31.92

33.51

umol/l

0.29

173

Acute sinusitis

764

4672

1.50

24.05

3.3

2.8

32.63

34.21

umol/l

1.31

706

4257

Monoamine oxidase A inhibitors

180

792

2.32

23.94

2.5

2.8

38.27

34.29

umol/l

0.36

161

725

Ill-defined and unknown causes of mortality

207

969

2.19

23.82

2.3

2.5

32.54

34.63

umol/l

0.59

188

850

Aortic valve malfunction, age under 60 years

205

957

2.20

23.81

3.4

3.3

38.87

36.28

umol/l

0.57

190

888

Pyothorax

118

430

2.87

23.71

2.9

2.8

39.80

33.74

umol/l

0.39

110

382

Collagenous colitis

176

772

2.34

23.70

3.1

2.8

31.91

35.16

umol/l

0.88

164

700

Pneumonia due to Streptococcus pneumoniae

275

3.35

23.68

3.2

32.59

36.19

umol/l

0.80

246

Colorectal adenocarcinoma

338

1849

1.83

23.63

2.1

2.5

32.01

32.92

umol/l

0.31

308

1637

Sleep disorders

1366

6979

1.36

23.63

2.4

2.8

32.23

34.13

umol/l

2.23

1228

6333

Glomerulonephritis

198

914

2.22

23.61

3.9

3.0

29.87

35.80

umol/l

2.90

184

836

Symptoms and signs involving the skin and subcutaneous tissue

1123

7689

1.39

23.55

2.6

2.7

32.61

33.62

umol/l

0.47

1019

6927

Cramp and spasm

111

392

2.94

23.54

4.0

3.2

30.66

34.67

umol/l

1.27

103

355

Certain disorders involving the immune mechanism

334

1851

1.84

23.48

2.8

3.0

30.24

35.00

umol/l

3.63

309

1694

Memory loss

173

757

2.35

23.46

2.1

2.6

28.43

35.03

umol/l

2.62

147

666

Dementia in other diseases classified elsewhere

104

355

3.04

23.43

2.0

2.7

28.87

35.19

umol/l

1.86

321

Other ill-defined and unspecified causes of mortality

191

874

2.24

23.29

2.2

2.6

31.35

34.38

umol/l

0.95

173

767

Benign neoplasms

1512

6174

1.34

23.27

3.2

2.6

33.79

umol/l

0.00

1371

5587

Osteoporosis with pathological fracture (FG)

130

501

2.66

23.17

3.5

2.3

33.68

32.68

umol/l

0.19

114

443

Total colectomy operation

101

342

3.08

23.14

3.8

3.4

30.91

34.23

umol/l

0.93

315

Total colectomy

101

342

3.08

23.14

3.8

3.4

30.91

34.23

umol/l

0.93

315

Migraine

614

3077

1.56

23.10

2.8

3.0

30.70

34.79

umol/l

5.20

555

2815

Use of pramipexole

363

2072

1.78

23.07

3.0

2.6

32.16

33.60

umol/l

0.54

317

1851

Symptoms and signs involving emotional state

179

3.95

23.06

2.1

3.7

30.31

35.84

umol/l

0.94

167

Phlebitis and thrombophlebitis (not including DVT)

350

1976

1.80

23.05

3.0

2.3

31.13

32.96

umol/l

0.90

320

1758

Undetermined asthma, excluding more controls

169

735

2.33

22.97

2.4

2.7

29.49

34.74

umol/l

2.56

152

661

Abnormal findings on diagnostic imaging of central nervous system

109

386

2.92

22.96

3.0

34.54

34.80

umol/l

0.03

350

L01XE Protein kinase inhibitors

124

472

2.73

22.88

2.2

2.8

40.63

33.12

umol/l

2.47

117

424

Pneumonia derived septicemia

303

3.21

22.83

3.0

3.2

35.00

34.12

umol/l

0.14

271

Eating disorders

148

609

2.47

22.79

2.7

2.8

29.99

32.82

umol/l

0.71

130

571

Specific development disorders of scholastic skills

265

3.32

22.76

3.0

3.4

35.69

33.99

umol/l

0.17

252

Personal history of other diseases and conditions

170

742

2.32

22.75

3.3

2.4

31.70

33.18

umol/l

0.42

161

688

Abnormal weight loss

189

872

2.22

22.59

2.4

2.7

31.15

34.45

umol/l

1.15

165

781

Other and unspecified mental retardation

201

3.88

22.56

2.4

4.0

35.16

36.01

umol/l

0.15

191

Strabismus

419

2496

1.70

22.52

2.6

2.9

32.32

34.16

umol/l

0.80

384

2267

Other metabolic disorders

186

851

2.22

22.50

2.5

2.7

32.81

34.11

umol/l

0.28

171

791

Mental retardation

112

405

2.87

22.45

2.3

3.7

34.37

33.38

umol/l

0.21

105

380

Generalized epilepsy, mode (most common among epilepsy diagnosis)

206

3.70

22.44

2.7

3.9

33.40

33.76

umol/l

0.05

191

Fitting and adjustment of other devices

516

2850

1.61

22.33

2.2

2.4

30.84

33.18

umol/l

1.62

461

2510

Amenorrhoea

332

3.01

22.18

2.9

2.8

30.91

32.51

umol/l

0.34

303

Sciatica+with lumbago

797

4868

1.46

22.07

2.5

2.7

32.64

34.50

umol/l

1.15

714

4431

Fracture of neck

137

558

2.54

21.93

2.3

2.7

29.01

34.02

umol/l

1.68

122

494

Malignant neoplasm of colon, including Hilmo

300

1635

1.86

21.93

2.2

2.4

32.60

33.09

umol/l

0.10

278

1442

Fracture of forearm

810

5043

1.45

21.91

2.4

2.7

31.33

33.96

umol/l

2.24

719

4559

Disturbance of activity and attention

182

813

2.22

21.87

3.3

2.9

33.89

32.48

umol/l

0.33

167

762

Later onset COPD

485

2414

1.63

21.86

1.8

2.0

30.83

32.17

umol/l

0.69

424

2083

Hypothyreosis and Thyroxine purchase for inclusion criteria

1351

6631

1.34

21.73

2.8

2.6

33.61

33.50

umol/l

0.05

1234

5953

Emotional disorders starting during childhood or adolescence

302

3.10

21.69

2.3

2.8

32.00

31.09

umol/l

0.22

288

Injuries involving multiple body regions

291

3.18

21.66

3.1

3.3

36.05

33.79

umol/l

0.31

266

Other systemic involvement of connective tissue (FG)

377

2171

1.72

21.60

2.2

2.6

30.13

33.78

umol/l

2.38

332

1937

Caries of dentine, including avohilmo

1195

4468

1.38

21.52

2.7

2.5

33.98

33.03

umol/l

0.43

1079

3990

Hypothyroidism, other/unspecified

1310

6438

1.34

21.45

2.8

2.7

33.57

33.58

umol/l

0.01

1194

5785

Other viral diseases, not elsewhere classified, including avohilmo

414

2484

1.68

21.34

3.1

3.0

32.59

34.42

umol/l

1.02

381

2281

Insulin, fast-acting (human)

214

1056

2.06

21.31

1.9

2.8

29.51

35.70

umol/l

2.45

190

956

Dental caries, including avohilmo

1116

4141

1.39

21.28

2.8

2.4

33.86

33.19

umol/l

0.26

1003

3694

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

129

518

2.55

21.18

1.9

2.9

32.35

36.36

umol/l

0.86

115

472

Mental retardation, wide definition

114

430

2.74

21.09

2.3

3.8

34.21

33.70

umol/l

0.10

107

404

Other congenital malformations of the digestive system, including avohilmo

128

511

2.58

21.07

6.6

3.0

36.62

32.74

umol/l

0.85

117

469

Alzheimer’s disease (Atypical or mixed), excluding more controls

130

379

2.61

21.06

1.4

1.8

25.59

34.70

umol/l

3.56

111

336

Crohn's disease NAS

127

511

2.55

20.81

3.9

3.3

33.93

36.19

umol/l

0.42

118

470

Injuries to the wrist and hand

1557

7946

1.31

20.75

2.7

34.13

33.40

umol/l

0.41

1415

7184

Heart failure and hypertrophic cardiomyopathy

176

3.91

20.73

3.2

32.22

33.40

umol/l

0.15

156

Second line medication for Crohn's disease

874

6223

1.41

20.61

2.9

2.8

32.85

34.08

umol/l

0.79

811

5634

Viral infections characterized by skin and mucous membrane lesions

671

4556

1.49

20.55

3.5

2.8

34.31

33.75

umol/l

0.25

617

4127

Diseases of pulp and periapical tissues and dental caries

999

3668

1.41

20.52

2.8

2.4

33.55

32.99

umol/l

0.19

899

3273

Open wound of ankle and foot

194

939

2.11

20.48

2.7

3.0

33.74

36.21

umol/l

0.61

176

867

Mycoses, including avohilmo

1406

8171

1.32

20.37

2.9

2.7

33.44

33.64

umol/l

0.11

1253

7400

Hyperkinetic disorders

195

921

2.09

20.30

3.2

3.1

33.49

32.40

umol/l

0.26

180

861

Secondary parkinsonism+Parkinsonism in other disease

241

3.36

20.29

2.0

3.1

29.91

33.12

umol/l

0.63

210

Primary_lymphoid and hematopoietic malignant neoplasms

407

2484

1.66

20.28

2.6

34.58

33.54

umol/l

0.33

372

2209

Superficial injuries involving multiple body regions

192

3.65

20.20

3.2

3.6

39.26

36.10

umol/l

0.34

176

Other fall from one level to another

384

2310

1.68

20.17

2.6

2.9

32.84

34.21

umol/l

0.57

347

2107

Disorders of ocular muscles, binocular movement, accommodation and refraction

706

4821

1.46

20.08

2.9

32.58

33.93

umol/l

0.85

648

4393

Other or ill-defined heart diseases

100

364

2.82

19.98

2.8

2.9

31.78

36.78

umol/l

0.98

333

Allergic asthma (mode), excluding more controls

242

1240

1.92

19.95

2.6

2.7

30.80

34.66

umol/l

2.23

223

1136

Burns and corrosions

248

1320

1.91

19.94

3.0

3.1

33.31

35.36

umol/l

0.61

232

1213

Insomnia

1303

6866

1.33

19.73

2.4

2.8

32.24

34.15

umol/l

2.15

1169

6235

Other arterial embolism and thrombosis

201

3.53

19.55

2.0

3.0

34.26

33.63

umol/l

0.05

178

Psoriasis

457

2898

1.60

19.43

3.6

2.8

35.84

33.99

umol/l

0.71

413

2639

Disorders of muscles

183

885

2.11

19.37

3.8

2.7

31.31

34.22

umol/l

0.85

168

812

Open wound of forearm

176

840

2.14

19.31

2.8

3.0

36.00

36.45

umol/l

0.05

156

767

Psoriasis vulgaris

322

1873

1.75

19.28

3.8

2.8

36.59

34.26

umol/l

0.67

292

1707

Viral pneumonia (unknown virus, not influenza)

136

586

2.38

19.22

4.1

3.0

31.64

35.13

umol/l

0.92

127

536

Malignant neoplasm of eye, brain and central nervous system

334

2.88

19.17

1.9

3.1

33.32

36.94

umol/l

0.50

306

Special screening examination for other diseases and disorders

179

863

2.10

18.97

3.1

2.3

31.88

34.76

umol/l

1.15

162

766

Other interstitial pulmonary diseases

272

1515

1.83

18.97

2.6

2.4

32.42

33.83

umol/l

0.44

257

1338

Vitamin B12 deficiency anaemia

172

821

2.14

18.85

2.3

34.05

32.44

umol/l

0.30

148

721

Other Crohn's disease

125

523

2.45

18.84

3.4

3.3

31.82

35.67

umol/l

1.01

117

488

Fibromyalgia

133

572

2.37

18.75

3.4

2.8

29.81

33.07

umol/l

1.41

119

524

Drug-induced adrenocortical insufficiency

141

4.06

18.74

2.7

3.4

28.73

34.19

umol/l

1.25

127

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

123

511

2.46

18.74

1.8

2.6

27.58

35.20

umol/l

3.66

106

453

Cough

580

3633

1.50

18.71

2.7

2.6

32.28

34.07

umol/l

1.31

518

3252

Presence of other functional implants

894

4413

1.40

18.70

2.5

2.3

32.67

34.12

umol/l

0.54

795

3957

Disorders of continuity of bone

170

811

2.14

18.67

3.4

2.9

32.90

34.69

umol/l

0.41

154

750

L04AX Other immunosuppressants

837

6024

1.40

18.65

2.9

2.8

33.01

34.05

umol/l

0.59

775

5451

Other aneurysm

111

443

2.58

18.59

3.2

2.8

35.44

35.83

umol/l

0.05

396

5-aminosalicylic acid

322

1891

1.72

18.56

3.7

2.9

30.49

35.29

umol/l

4.74

300

1717

Myalgia

349

2094

1.68

18.54

3.6

2.7

32.48

33.69

umol/l

0.42

329

1900

Deforming dorsopathies

408

2545

1.62

18.53

2.2

2.8

32.44

34.24

umol/l

0.61

376

2323

Amyloidosis

151

3.89

18.50

1.5

2.4

32.65

35.02

umol/l

0.17

133

Interstitial lung disease endpoints

272

1527

1.81

18.49

2.6

2.4

32.42

33.75

umol/l

0.41

257

1350

Interstitial lung disease

272

1527

1.81

18.49

2.6

2.4

32.42

33.75

umol/l

0.41

257

1350

Amyloidosis, other/unspecified

129

4.18

18.46

1.5

2.5

33.30

33.46

umol/l

0.01

113

Gingivitis and periodontal diseases

1509

6038

1.30

18.42

2.8

2.6

33.76

33.47

umol/l

0.13

1350

5433

Reimbursement for rheumatic diseases

823

5885

1.40

18.41

3.3

2.6

31.70

33.96

umol/l

2.55

767

5277

Hypothyroidism, strict autoimmune, 3 medication purchases required

1177

5963

1.33

18.34

2.8

2.6

33.49

33.53

umol/l

0.02

1080

5348

Barrett oesophagus

108

429

2.60

18.31

3.3

2.4

33.45

35.78

umol/l

0.30

380

Infective dermatitis

202

1034

1.99

18.31

2.8

3.0

31.06

35.21

umol/l

1.75

181

940

Malignant neoplasm of brain, including Hilmo

359

2.75

18.31

1.7

3.1

29.30

36.33

umol/l

1.51

329

ILD, hospital admissions

268

1503

1.82

18.29

2.7

2.4

32.55

33.66

umol/l

0.32

253

1334

Pneumococcal septicemia

305

2.94

18.28

3.0

3.4

35.27

34.54

umol/l

0.11

274

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

141

631

2.29

18.25

2.7

2.8

35.47

34.79

umol/l

0.11

132

564

Diseases of oral cavity, salivary glands and jaws

882

3255

1.41

18.18

2.7

2.4

33.41

33.43

umol/l

0.01

785

2920

Secondary parkinsonism

242

3.21

18.17

2.0

3.1

29.81

33.59

umol/l

0.77

211

Lichen simplex chronicus and prurigo

122

514

2.44

18.17

2.8

2.9

29.50

36.51

umol/l

2.10

107

464

Other arthritis (FG)

467

3025

1.56

18.09

2.4

2.8

30.80

34.23

umol/l

3.05

425

2722

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

380

2.69

17.99

2.9

2.3

35.04

33.21

umol/l

0.27

339

Non-allergic asthma (mode), excluding more controls

210

1083

1.94

17.92

2.4

2.7

33.26

34.87

umol/l

0.45

181

974

Diseases of the musculoskeletal system and connective tissue

775

2726

1.43

17.85

3.1

2.7

35.09

34.39

umol/l

0.20

711

2482

Other and unspecified degenerative diseases of nervous system

224

3.27

17.81

2.3

2.8

24.51

35.65

umol/l

4.52

197

Unspecified misadventure during surgical and medical care

116

483

2.47

17.78

3.0

2.7

31.43

33.00

umol/l

0.34

108

434

Asthma, hospital admissions , main diagnosis only

1212

8062

1.31

17.76

2.6

2.8

32.07

33.84

umol/l

1.95

1091

7286

Diplopia

227

1221

1.89

17.74

2.6

2.9

31.20

34.26

umol/l

1.21

203

1104

Congenital malformations of the circulatory system

259

1412

1.81

17.54

4.1

3.0

33.89

34.31

umol/l

0.11

247

1296

Other specific joint derangements/joint disorders

1070

4985

1.34

17.49

2.9

2.8

33.00

34.01

umol/l

0.74

960

4520

Undetermined asthma

169

823

2.08

17.46

2.4

2.7

29.49

35.01

umol/l

2.80

152

739

Polyuria

372

2310

1.63

17.38

2.6

2.5

30.60

33.36

umol/l

1.53

315

2072

Cerebral aneurysm, nonruptured

143

657

2.22

17.35

2.7

3.0

34.09

36.06

umol/l

0.35

128

600

Open wound of abdomen, lower back and pelvis

259

3.05

17.33

3.7

3.3

33.07

34.47

umol/l

0.20

240

Car occupant injured in other and unspecified transport accidents

280

1619

1.75

17.13

3.1

2.9

31.86

33.98

umol/l

0.87

254

1487

Late syphilis, including avohilmo

137

3.96

17.07

2.7

3.5

32.54

34.32

umol/l

0.21

127

Disorders of skin appendages

706

4993

1.42

17.00

2.9

2.8

32.89

33.65

umol/l

0.37

646

4544

Other systemic involvement of connective tissue

387

2438

1.60

16.97

2.2

2.5

30.27

33.37

umol/l

1.82

342

2178

Other diseases of lip and oral mucosa

624

4345

1.45

16.96

3.1

2.8

34.86

33.85

umol/l

0.45

564

3942

Malignant neoplasm of brain

258

3.01

16.79

1.6

3.2

29.84

36.99

umol/l

1.08

238

Burns and corrosions of external body surface, specified by site

194

1010

1.96

16.79

3.1

32.28

35.57

umol/l

1.39

179

926

Disturbances of skin sensation

386

2438

1.60

16.74

2.3

2.9

32.28

34.10

umol/l

0.60

346

2218

Moderate visual impairment, binocular

222

3.18

16.68

1.8

2.9

31.32

35.87

umol/l

0.92

191

Other surgical follow-up care

202

3.27

16.55

2.3

3.4

35.12

34.90

umol/l

0.02

183

Disorders of the thyroid gland

1380

6995

1.29

16.46

2.8

2.7

33.28

33.56

umol/l

0.15

1250

6277

Polycystic ovarian syndrome, consortium definition

767

3141

1.41

16.46

2.7

2.5

31.79

32.89

umol/l

0.64

694

2832

D07AA Corticosteroids, weak (group I)

243

1364

1.80

16.43

2.4

3.0

32.94

35.12

umol/l

0.71

227

1257

Benign neoplasm: Caecum

197

1041

1.93

16.37

2.9

2.7

36.18

33.78

umol/l

0.47

172

932

Malignant neoplasm of colon

240

1347

1.81

16.33

2.2

2.4

30.02

33.16

umol/l

1.56

221

1195

Other intracranial haemorrhages

241

3.06

16.31

2.5

28.30

34.91

umol/l

1.83

212

Other strabismus

323

1960

1.66

16.27

2.6

3.0

32.38

34.51

umol/l

0.80

298

1795

Immunodeficiencies

388

2.58

16.26

2.0

3.5

27.06

36.00

umol/l

5.52

356

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

367

1888

1.62

16.15

1.9

2.4

32.42

32.80

umol/l

0.11

322

1666

Other and unspecified psoriasis

131

600

2.24

16.12

3.4

2.7

36.61

35.40

umol/l

0.14

112

545

Pneumonia due to other infectious organisms, not elsewhere classified

217

3.14

15.99

3.0

3.2

30.66

36.93

umol/l

1.53

192

Abscess of lung

139

3.83

15.96

3.5

3.6

34.91

35.05

umol/l

0.01

129

Special screening examination for infectious and parasitic diseases

275

1158

1.74

15.95

3.3

2.6

36.19

36.39

umol/l

0.05

235

1048

Allergic asthma (mode)

242

1334

1.78

15.92

2.6

2.7

30.80

34.71

umol/l

2.30

223

1226

Anoxic brain damage

112

4.19

15.89

1.8

3.9

37.59

35.56

umol/l

0.13

Mucosal proctocolitis

206

1115

1.88

15.82

4.1

3.1

32.23

35.41

umol/l

1.26

186

1027

Infections with a predominantly sexual mode of transmission

369

2334

1.59

15.73

3.4

3.0

32.25

34.27

umol/l

1.12

338

2146

Emphysema

147

712

2.11

15.68

2.1

2.6

32.04

35.03

umol/l

0.75

133

635

Fracture at wrist and hand level

529

3615

1.47

15.65

2.7

3.0

34.44

33.82

umol/l

0.26

469

3287

Vascular dementia (mixed)

136

3.77

15.57

1.2

2.1

23.11

35.20

umol/l

2.76

121

Stomatitis and related lesions

302

1831

1.67

15.56

2.7

2.8

34.02

34.21

umol/l

0.05

269

1666

Problems related to social environment

195

3.24

15.50

2.8

2.9

26.88

32.16

umol/l

1.64

172

Embolic stroke with flimmer

155

3.54

15.50

1.6

2.5

26.79

32.36

umol/l

1.40

139

Hemiplegia

391

2.52

15.46

2.5

3.1

31.88

34.52

umol/l

0.69

347

Arthropathies

1308

5146

1.29

15.42

2.9

2.8

34.56

33.91

umol/l

0.29

1193

4657

Benign neoplasm: Ascending colon

249

1440

1.76

15.40

2.9

2.6

34.47

33.65

umol/l

0.16

222

1286

DVT of lower extremities

276

1640

1.70

15.36

3.1

2.1

31.38

32.79

umol/l

0.48

250

1452

Migraine with aura

272

1608

1.70

15.30

2.2

2.9

30.23

34.66

umol/l

2.69

248

1482

Sequelae of other external causes

109

473

2.36

15.27

2.7

3.0

33.60

35.67

umol/l

0.32

102

428

Spondyloarthritis

268

1583

1.71

15.24

2.8

2.9

31.11

34.85

umol/l

2.49

244

1438

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

476

3215

1.49

15.23

2.9

2.8

31.77

33.90

umol/l

1.20

422

2919

Other abnormalities of plasma proteins

125

3.90

15.16

2.2

2.5

30.86

33.03

umol/l

0.28

115

Prurigo nodularis

205

3.16

15.00

2.6

3.2

30.28

34.77

umol/l

0.84

185

Papulosquamous disorders

588

4147

1.43

14.99

3.4

2.8

35.32

33.74

umol/l

0.74

530

3755

Other disorders of nervous system

126

586

2.20

14.96

2.0

2.8

28.95

36.98

umol/l

3.43

120

533

Drug-induced cataract

190

3.25

14.93

5.0

3.6

38.93

34.35

umol/l

0.33

175

Coronary artery bypass grafting

422

2053

1.54

14.89

1.8

2.4

29.79

34.16

umol/l

3.05

378

1810

Unspecified urinary incontinence

134

639

2.14

14.84

3.3

2.6

31.37

32.33

umol/l

0.13

118

576

Migraine without aura

213

1186

1.81

14.82

3.1

31.03

35.51

umol/l

2.30

194

1091

Hydrocephalus

132

628

2.15

14.77

1.8

2.6

27.77

33.76

umol/l

2.98

116

562

Diabetic retinopathy

703

3149

1.40

14.74

2.5

3.1

30.51

35.55

umol/l

7.91

620

2856

Asthma, including avohilmo

1766

7898

1.24

14.74

2.6

2.8

32.08

33.98

umol/l

2.97

1599

7128

Hypopituitarism

142

697

2.08

14.64

3.8

3.2

32.71

35.21

umol/l

0.53

130

648

Other specified/unspecified arthritis

402

2646

1.53

14.60

2.4

2.7

30.53

34.04

umol/l

2.79

366

2385

Cystic kidney disease, including avohilmo

291

2.74

14.56

2.5

3.5

31.44

34.62

umol/l

0.36

266

Dental operations

913

3512

1.34

14.52

2.8

2.4

34.04

33.54

umol/l

0.16

819

3129

IBD patients in KELA-register

334

2119

1.59

14.33

3.5

3.0

30.68

34.97

umol/l

4.20

310

1951

Polycystic kidney disease

216

3.04

14.32

2.7

3.3

29.09

33.12

umol/l

0.63

198

Congenital malformations of heart and great arteries

224

1245

1.77

14.27

4.0

3.1

33.37

34.69

umol/l

0.40

215

1145

Cervicalgia

296

1826

1.64

14.27

2.6

2.8

31.95

34.56

umol/l

0.93

256

1661

Other disorders of veins

533

3670

1.44

14.14

3.1

2.2

33.78

32.98

umol/l

0.33

479

3257

Diabetic retinopathy, strict definition

350

1999

1.58

14.09

2.5

3.3

29.25

35.79

umol/l

8.24

312

1831

Corticotropin deficiency

5.09

14.09

4.3

2.9

34.69

34.75

umol/l

0.00

Malignant neoplasm of head and neck, including Hilmo

164

859

1.94

14.02

2.5

2.7

31.42

34.68

umol/l

0.83

144

763

Postprocedural endocrine and metabolic disorders, not elsewhere classified

149

754

2.00

14.00

2.2

2.6

32.57

33.97

umol/l

0.25

137

699

Inflammatory diseases of female pelvic organs

661

3260

1.39

13.97

3.1

2.5

34.96

32.28

umol/l

1.62

600

2943

Heartburn

147

742

2.01

13.93

2.9

2.2

29.96

31.66

umol/l

0.52

130

672

Unstable angina pectoris

556

3073

1.43

13.92

2.2

2.5

29.19

34.07

umol/l

5.21

473

2721

Visual field defects

148

752

2.01

13.87

2.9

2.8

32.71

36.14

umol/l

0.82

137

671

Alzheimer’s disease (Early onset), excluding more controls

155

3.28

13.87

1.9

2.4

30.41

37.86

umol/l

0.85

137

Colon adenocarcinoma

191

1055

1.84

13.82

2.2

2.4

30.04

33.67

umol/l

1.65

176

924

ILD, hospital admissions 1, main diag only

233

1365

1.74

13.81

2.7

2.5

32.83

33.87

umol/l

0.27

221

1216

Other and unspecified intracranial injuries

237

2.88

13.76

1.8

3.3

28.71

33.01

umol/l

1.29

213

Asthma/COPD (KELA code 203)

1360

7261

1.26

13.66

2.3

2.8

31.63

34.02

umol/l

3.29

1222

6551

Other necrotizing vasculopathies

129

628

2.10

13.64

1.9

2.7

27.00

34.21

umol/l

4.53

114

561

Cystic kidney disease

278

2.73

13.64

2.6

3.5

28.80

34.33

umol/l

1.22

253

Non-Hodgkin lymphoma, all, including Hilmo

200

1125

1.80

13.63

2.7

2.5

33.76

33.61

umol/l

0.03

189

1005

Malignant neoplasm of urinary organs, including Hilmo

183

1003

1.85

13.61

1.7

2.5

27.03

33.89

umol/l

4.63

157

892

Benign neoplasm: Sigmoid colon

309

1957

1.60

13.46

3.7

2.6

36.39

33.40

umol/l

0.93

282

1739

Other neurotic disorders

368

2.46

13.46

2.2

2.9

30.04

38.03

umol/l

1.68

331

Other ulcerative colitis

102

455

2.29

13.44

3.8

3.1

29.80

35.92

umol/l

1.87

422

Urticaria and erythema

486

3384

1.45

13.32

3.2

2.8

32.56

33.61

umol/l

0.49

443

3081

Lesion of lateral popliteal nerve

420

2.35

13.28

3.5

3.0

29.52

36.74

umol/l

1.74

378

Spondylosis

812

4781

1.34

13.27

2.3

2.7

32.91

34.31

umol/l

0.77

710

4328

Adverse effects, not elsewhere classified

271

1668

1.64

13.23

2.5

3.0

32.56

34.70

umol/l

0.84

251

1531

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

502

3474

1.44

13.21

2.5

3.0

33.91

34.19

umol/l

0.09

463

3196

Periapical abscess

705

5237

1.36

13.18

2.8

3.0

33.85

34.19

umol/l

0.15

624

4790

Malignant neoplasm of head and neck

141

721

1.99

12.99

2.6

31.50

34.65

umol/l

0.68

123

642

Familial hypercholesterolemia, with ischemic heart disease

156

826

1.93

12.99

2.6

2.5

30.86

34.29

umol/l

1.07

135

717

Malignant neoplasm of oral cavity, including Hilmo

350

2.47

12.97

2.5

2.7

31.01

36.52

umol/l

0.79

320

Vitreous haemorrhage

175

962

1.85

12.95

2.3

2.9

27.11

35.98

umol/l

5.84

155

867

Other specified/unspecified bacterial intestinal infections

114

541

2.15

12.91

3.1

2.9

32.16

34.72

umol/l

0.64

104

485

Diffuse large B-cell lymphoma, including Hilmo

401

2.36

12.86

1.8

2.5

33.12

36.53

umol/l

0.45

359

Diffuse large B-cell lymphoma

401

2.36

12.86

1.8

2.5

33.12

36.53

umol/l

0.45

359

Diffuse large B-cell lymphoma, helper endpoint

401

2.36

12.86

1.8

2.5

33.12

36.53

umol/l

0.45

359

Secondary and unspecified malignant neoplasm of lymph nodes

137

697

2.00

12.82

2.0

2.7

32.23

35.24

umol/l

0.76

124

630

Non-allergic asthma (mode)

210

1206

1.74

12.81

2.4

2.6

33.26

34.86

umol/l

0.45

181

1085

Need for other prophylactic measures

110

517

2.18

12.80

4.3

3.2

37.08

36.68

umol/l

0.05

100

473

Injury of unspecified body region

131

657

2.03

12.77

2.3

2.9

30.15

35.28

umol/l

1.75

122

595

Other other unspecified disorders of the circulatory system

305

2.57

12.77

4.6

3.1

35.50

34.77

umol/l

0.09

274

Corns and callosities

113

537

2.15

12.75

2.4

2.8

32.99

35.95

umol/l

0.46

101

483

Other and unspecified acquired haemolytic anaemias

4.52

12.73

6.3

3.0

32.38

35.63

umol/l

0.30

Inflammatory bowel disease, strict (require KELA)

334

2183

1.55

12.64

3.5

3.0

30.68

34.99

umol/l

4.28

310

2009

Drug-induced neutropenia

124

613

2.07

12.62

2.4

2.9

35.00

33.39

umol/l

0.24

108

556

Postmenopausal osteoporosis with pathological fracture

429

2.28

12.60

2.7

2.2

32.26

31.16

umol/l

0.18

370

Malignant neoplasm of oral cavity

267

2.67

12.48

2.4

2.8

30.05

37.71

umol/l

1.00

245

Superficial injury of wrist and hand

293

1865

1.59

12.47

3.1

3.0

33.22

33.64

umol/l

0.12

268

1715

Varicose veins of other sites

110

524

2.14

12.35

6.2

2.3

37.88

35.56

umol/l

0.37

467

Thyroiditis, ILD-related definition

154

825

1.89

12.32

2.5

2.8

32.39

33.31

umol/l

0.26

140

757

Pneumocystosis, including avohilmo

170

3.16

12.28

2.5

3.2

30.91

34.40

umol/l

0.63

151

Pneumocystosis

170

3.16

12.28

2.5

3.2

30.91

34.40

umol/l

0.63

151

Statin medication

907

3924

1.31

12.21

3.0

32.67

35.59

umol/l

3.03

828

3597

Benign neoplasm: Transverse colon

192

1106

1.77

12.19

3.2

2.7

38.22

34.61

umol/l

0.68

172

989

Small fibre neuropathy

278

2.62

12.09

5.6

3.2

33.92

33.44

umol/l

0.06

245

Bacterial, viral and other infectious agents, including avohilmo

150

804

1.90

12.05

4.7

3.2

38.68

36.10

umol/l

0.52

137

744

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

397

2.29

12.01

3.8

3.3

33.12

32.44

umol/l

0.15

369

Other disorders of the musculoskeletal system and connective tissue

228

1380

1.68

12.00

2.6

2.8

32.49

34.09

umol/l

0.41

200

1257

Mixed hyperlipidaemia

302

2.52

11.99

2.6

2.7

34.26

35.44

umol/l

0.14

273

Other specified disorders of muscle

238

2.74

11.98

2.5

2.6

28.91

34.27

umol/l

1.51

214

Hypertrophic cardiomyopathy

383

2.34

11.96

3.0

2.9

32.56

36.00

umol/l

0.52

341

Superficial injury of forearm

151

813

1.88

11.92

2.6

3.1

30.69

35.45

umol/l

1.95

137

750

3.89

11.90

2.0

3.4

26.74

34.57

umol/l

2.42

Lumbar disc prolapse

906

5207

1.29

11.89

2.6

2.7

33.26

34.33

umol/l

0.60

817

4734

Abdominal aortic aneurysm (AAA)

156

843

1.86

11.86

1.8

2.2

29.73

33.98

umol/l

1.29

134

722

Other necrotizing vasculopathies (FG)

104

494

2.15

11.80

1.9

2.8

26.97

34.53

umol/l

3.88

445

Necrosis of pulp, including avohilmo

829

6325

1.30

11.77

2.9

34.13

34.21

umol/l

0.03

764

5777

Malignant neoplasm of rectum, including Hilmo

186

1072

1.76

11.74

2.2

2.5

36.43

33.90

umol/l

0.55

167

959

Restless leg syndrome

209

1244

1.70

11.73

2.7

2.8

32.23

34.41

umol/l

0.69

187

1130

Embolic stroke

335

2.41

11.72

1.7

2.7

27.92

35.03

umol/l

2.44

297

Benign neoplasm: Stomach

157

862

1.85

11.72

3.8

2.7

38.01

34.81

umol/l

0.65

145

782

Bacterial, viral and other infectious agents

141

748

1.92

11.71

4.8

3.3

38.86

35.92

umol/l

0.58

130

692

Irregular menses

473

2506

1.42

11.60

3.2

2.7

32.23

33.20

umol/l

0.41

447

2299

Pyogenic arthritis

119

598

2.03

11.60

3.0

2.7

34.01

umol/l

0.00

107

540

Other and unspecified injuries of lower leg

117

585

2.03

11.52

2.8

3.1

32.87

33.78

umol/l

0.17

108

541

Myelodysplastic syndrome, including Hilmo

220

2.77

11.51

2.8

2.5

32.87

36.23

umol/l

0.46

199

Vascular dementia (subcortical)

249

2.64

11.46

2.0

2.1

29.43

34.13

umol/l

0.62

218

Non-Hodgkin lymphoma, all

358

2.35

11.46

2.5

35.57

35.95

umol/l

0.04

321

Cardiac murmurs and other cardiac sounds

141

745

1.90

11.38

3.3

2.9

33.62

33.58

umol/l

0.01

135

685

Other epidermal thickening

366

2.33

11.33

2.4

2.9

31.14

34.15

umol/l

0.88

331

Olecranon bursitis

121

621

1.99

11.16

2.8

2.6

32.85

34.25

umol/l

0.32

114

569

Autism

157

3.07

11.16

1.5

4.3

31.15

35.61

umol/l

0.98

151

Dissection of aorta

259

2.59

11.13

2.1

3.0

33.45

33.65

umol/l

0.03

229

Anorexia (incl.atypical)

330

2.37

11.13

2.6

3.3

29.56

34.28

umol/l

1.41

301

Oesophageal obstruction

277

2.53

11.11

2.7

2.1

28.41

34.51

umol/l

1.77

245

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

157

877

1.82

11.08

1.7

2.6

27.05

34.60

umol/l

4.53

134

781

Dementia due to Parkinsons disease, excluding more controls

107

3.55

11.07

1.5

2.5

23.67

34.81

umol/l

3.57

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

160

899

1.81

11.07

2.0

2.6

34.65

34.25

umol/l

0.06

145

802

Salpingitis and oophoritis

198

1180

1.70

11.05

3.1

2.6

37.77

32.27

umol/l

1.40

177

1082

Aortic aneurysm

369

2484

1.47

11.05

2.3

2.4

30.78

33.93

umol/l

1.80

328

2198

Abscess of anal and rectal regions

133

706

1.91

11.03

2.8

2.9

32.03

34.83

umol/l

0.93

127

656

Chronic tubulo-interstitial nephritis

191

2.84

10.97

2.8

2.5

31.88

33.86

umol/l

0.34

168

Malignant neoplasm of urinary organs

154

858

1.82

10.97

1.7

2.6

27.21

34.91

umol/l

4.55

131

762

Right hemicolectomy

106

523

2.07

10.93

2.9

2.7

35.69

34.84

umol/l

0.10

100

460

Benign neoplasm: Duodenum

227

2.70

10.91

5.2

2.6

36.81

32.43

umol/l

0.62

199

Malignant neoplasm of bronchus and lung, including Hilmo

305

1676

1.53

10.90

1.8

2.4

32.50

32.99

umol/l

0.14

264

1481

Schizotypal disorder

144

3.16

10.86

1.9

3.8

30.08

35.07

umol/l

0.99

137

Convalescence

322

2.37

10.86

3.8

2.8

32.64

34.04

umol/l

0.21

295

Crohn's disease of large intestine

392

2.24

10.85

3.1

3.4

30.47

34.29

umol/l

1.37

363

Contact with heat and hot substances

451

2.15

10.83

3.1

3.4

35.15

34.79

umol/l

0.04

412

Other disorders of white blood cells

472

2.13

10.78

2.6

2.8

35.44

33.57

umol/l

0.24

426

Bulimia nervosa (incl. atypical)

124

3.29

10.72

1.8

2.9

26.60

32.21

umol/l

1.13

112

Benign neoplasm: Small intestine

344

2.34

10.72

4.5

2.8

35.92

33.12

umol/l

0.39

310

Intermittent heterotropia

100

485

2.10

10.71

2.3

3.1

28.16

32.84

umol/l

2.09

449

Hyperfunction of pituitary gland

318

2.37

10.71

1.9

3.0

29.79

32.33

umol/l

0.65

292

Myocardial infarction, unclassifiable

330

1987

1.50

10.71

2.4

2.2

31.28

32.99

umol/l

0.71

289

1705

Car occupant injured in noncollision transport accident

276

2.49

10.69

2.2

3.3

38.00

33.36

umol/l

0.60

254

Other disorders of optic [2nd] nerve and visual pathways

110

555

2.02

10.66

3.3

3.0

32.96

35.12

umol/l

0.52

505

Persons with potential health hazards related to communicable diseases

465

3317

1.40

10.65

3.1

33.12

34.54

umol/l

0.75

434

3059

Congenital malformations of the urinary system

102

502

2.08

10.59

2.5

3.3

30.11

35.82

umol/l

1.37

461

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

147

819

1.83

10.52

2.9

3.0

35.34

35.80

umol/l

0.07

131

741

Benign neoplasm of other and unspecified endocrine glands

202

1231

1.66

10.44

2.2

2.8

31.10

34.22

umol/l

1.23

184

1121

Lesion of radial nerve

304

2.40

10.42

2.6

3.2

37.90

34.93

umol/l

0.32

276

Postprocedural musculoskeletal disorders, not elsewhere classified

121

637

1.94

10.37

2.3

2.8

31.92

34.85

umol/l

0.54

102

573

Multiple myeloma, including Hilmo

355

2.28

10.36

1.9

2.7

28.59

34.67

umol/l

1.73

316

Benign neoplasm: Rectum, anus and anal canal

307

2065

1.50

10.29

3.2

2.6

34.34

33.44

umol/l

0.24

257

1840

Progressive vascular leukoencephalopathy

281

2.44

10.28

1.7

2.2

24.62

33.41

umol/l

3.24

241

Dermatophytosis

220

1375

1.62

10.28

2.5

2.7

31.78

34.18

umol/l

0.65

192

1252

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ammonium ion [Moles/volume] in Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS